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From the Residency Program Director

The goal of a Residency Program in Internal Medicine is to
strive to train the next generation of practitioners and
academicians in Medicine who will become physiciansscholars, scientists, teachers, and humanists.
We are excited that many of our residents are pursuing
research opportunities in the laboratory or clinic. Such
participation is a requirement for training at Jefferson. In
addition, this journal serves as an outlet for scholarly work of
a variety of types. We are pleased to support another issue of
the Jefferson Forum to continue to highlight this work. This
represents the fifth installment of Jefferson Forum, which first
debuted in 1999. The journal is supported entirely through
private contributions and unrestricted educational grants.
Subscriptions to the members of the Department of Medicine
are provided at no cost. The editors have maintained

complete editorial independence to assemble and peer review
the submissions for this installment.
The editors deserve our praise for a job well done. Please
recognize that the creation of this journal is accomplished by
a small team who still have to contend with the daily rigors of
residency including night call, teaching their inpatient teams,
long days, and preparing for boards. I thank them for
extending Jefferson’s tradition of excellence in education and
enhancing the experience of our residents.
Gregory C. Kane, MD
Associate Professor of Medicine
Residency Program Director
Department of Medicine

Editors Aparna Mukherjee, MD, Nicole Weinberg, MD, Nicholas Ruggiero, MD
My co-editors and I welcome you to the 5th edition of the
Jefferson Medicine Forum. This annual publication is a
compilation of scholarly works produced by Jefferson’s
Internal Medicine residents. We are especially proud of this
year’s edition, which includes a wide variety of case
presentations, individual research pursuits, reviews of
interesting medical topics, and provocative images reflecting
important disease processes. We applaud the efforts of our
contributing authors for their commitment to scholarly
pursuit during their residency training and their hard work in
producing the articles which fill these pages. We proudly
present them to you now. Happy reading!
Aparna Mukherjee, MD
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Case Presentations

A Man With A Soft Tissue Lesion Of The Hand
Susan Masonis MD, PGY-3 Internal Medicine

A fifty year old male presents with a lesion on his right
hand. Approximately 2 months prior to presentation, the
patient, who is a dentist and avid boater, first noted the
lesion after hitting his hand when working in his boat’s
engine room. Initially he had a 1 cm erythematous
macular lesion on the dorsum of his right hand at the
5th metacarpal. He believed the lesion was present prior
to the time he struck his hand, and the injury brought it
to his attention.
A week later, the erythematous region became raised and
a central pustule formed. The lesion was tender to
palpation and a small satellite lesion was also noted (See
Figure A, Color Plates page 19). The initial lesion
eventually ulcerated and drained serosanguinous fluid.
The patient took a 7-day course of cephalexin without
significant improvement.
The patient was seen by a dermatologist after the course
of antibiotics. The dermatologist prescribed a 3rdgeneration cephalosporin and cultured the discharge.
After a 7-day course of this second antibiotic, there was
no improvement in the lesion and the patient sought
advice from a plastic surgeon. The surgeon unroofed the
lesion and sent tissue and fluid for both routine bacterial
and mycobacterial culture. Four weeks later the patient
returned to the surgeon and received a corticosteroid
injection to reduce the inflammation. At that time he
was told that there was no growth on the cultures.
The patient’s past medical history includes hypertension,
atopic dermatitis, asthma and hyperlipidemia. As
previously stated, he works as a dentist and reports always
wearing gloves during procedures. Outside of work, he
owns a boat and spends most of his free time sailing in
the Chesapeake Bay.
Six weeks after the surgeon performed the culture, the
laboratory reported a mycobacterial species had been
isolated and the patient was referred to an infectious
diseases specialist. The final culture grew Mycobacterium
marinum. The patient has improved on current oral
antibiotic therapy with clarithromycin and rifampin.

Non-tuberculous mycobacteria in soft tissue lesions
Non-tuberculous mycobacterium infections can present
with an assortment of cutaneous findings. During the
past two decades, there has been an increase in the
incidence of non-tuberculous mycobacterial infections,
due in large part to an increase in the number of
surgical procedures and number of immunocompromised individuals.
The most common mycobacteria involved in
cutaneous infections include M. marinum, M.
ulcerans, M. fortuitum, M. chelonei and M. abscessus.
These infections may present as nodules, abscesses,
ulcerations or cellulitis. M. abscessus and M. fortuitum
infections are often associated with surgical procedures;
the former is also associated with post injection
abscesses. M. chelonei is most often reported in
individuals using systemic corticosteroids. M. ulcerans,
previously noted predominately in regions near
temperate rainforests, has recently been associated with
several post-surgical infections.
Mycobacterium marinum is an organism found in both
saltwater and freshwater. Several vectors of transmission
have been reported, including fish, shrimp, snails and
water fleas. Most human infections are acquired from
direct contact with water. The term “fish tank
granuloma” refers to M. marinum cutaneous infection,
arising from aquarium maintenance. Infection is usually
established following skin abrasions or other minor
trauma. After a two to six week incubation period, a
nodule or papule typically appears. The lesions are
usually solitary, with 20-40% developing a sporotichoid
distribution (additional proximal lesions along the
lymphatic channel).
Infections with this organism are usually limited to skin,
because optimal growth of M. marinum is between 30
and 33 degrees Celsius. However, M. marinum can
spread to deeper structures and cause tenosynovitis,
arthritis, and osteomyelitis. Such deep extension has a
higher incidence of treatment failure. Disseminated
infections with M. Marinum are rare.
(Continued on next page)
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Successful diagnosis and treatment of cutaneous
infection due to non-tuberculous mycobacteria require a
high index of suspicion and proper cultures. A clinician
should consider mycobacteria in any patient presenting
with a non-healing or draining nodule, chronic
panniculitis or cellulitis, and particularly if the patient
has a recent history of trauma, immunosuppression, or
surgery. An adequate tissue sample, defined as a 6 mm
punch biopsy, should be sent for analysis.
Routine bacterial cultures often provide false negative
results, because standard incubation temperature is 37
degrees Celsius. The physician must alert the laboratory
if non-tuberculous mycobacterium is suspected.
Standard mycobacterial media can then be utilized,
usually at lower incubation temperatures. M. Marinum
typically begins to grow within 10 to 28 days, but
cultures should be held for at least six weeks.
Optimal treatment for M. marinum cutaneous infection
has not been established. The Archives of Internal
Medicine recently published a review of 63 cases of M.
marinum cutaneous infections occurring between 1996
and 1998. Prior to this report, only case studies were
available. The most frequently used antibiotics in this
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review
included
clarithromycin,
doxycycline,
minocycline, rifampin, and ethambutol. The authors
noted that all strains of M. Marinum in these patients
had similar antimicrobial susceptibility patterns.
Acquired antimicrobial resistance did not occur during
therapy. Therapy duration ranged from 1-25 months
with a median of 3.5 months. The duration was
significantly longer for deeper structure infections. There
was a 93% cure rate for individuals with soft tissue
infection only. One-half of those individuals who were
successfully treated received monotherapy and the other
half received dual antimicrobial therapy. No conclusive
recommendations were made for treatment of this
infection. However, clarithromycin with rifampin was
the most common combination prescribed, and
minocycline or doxycyline were most frequently
employed as monotherapy.
References
1. Aubry, A.,Chosidow, O., Sixty-three Cases of
Mycobacterium marinum Infection. Archives of Internal
Medicine. 2002;162:1746-1752.
2. Weitzul, S., Eichorn, P., Pandya, A., Nontuberculous
Mycobacterial Infections of the Skin. Dermatologic
Clinics. April, 2000; 18:2.
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A Man With an Elevated Hemoglobin
Paula Sorokanich MD, PGY-3 Internal Medicine

A 50-year-old male with history of severe gout and
degenerative joint disease presented to his PCP for a
physical. On routine blood work he was found to have
an elevated hemoglobin/hematocrit. This was confirmed
on repeat analysis and work-up was pursued.
His past medical and surgical history includes
hypertension, severe gout, degenerative joint disease of
the knees and shoulders, hypokalemia, and right ulnar
nerve manipulation at the elbow. He denied IV drug or
tobacco use, although he occasionally smokes cannabis,
and has a history of moderate alcohol use for which he
was in rehabilitation in 1998. His parents are both alive
with diabetes and hypertension, and he has three healthy
siblings. There is no family history of blood disorders.
He denied any recent travel and has always lived in
Delaware or Maryland except when stationed in
Germany when he was in the military. He lives alone and
previously worked as an item processor.
On review of systems, he denied fevers, sweats, or chills.
He had noted an approximate 15lb weight gain over the
past year, which he attributed to dietary indiscretions.
He denied any change in vision, or hearing and had not
experienced any lightheadedness or dizziness. He denied
chest pain, shortness of breath, but occasionally notes
palpitations with increased activity. He also denied skin
changes, flushing, or pruritus.
His medications include:
Allopurinol 300mg po qd
Folic acid 1mg po qd
Magnesium oxide 420mg po qd
Multivitamin 1 tab po qd
Naprosyn 500mg po bid prn
Potassium chloride 8meq po qd
Thiamine 100mg po qd
ASA 325mg po qd
Physical examination revealed a ruddy-faced male, in no
acute distress, with stable vital signs. Significant findings
included hepatomegaly at 16cm and a spleen tip palpable
3-4 fingerbreadths below the costal margin. His left third
digit PIP had mild erythema and swelling, per his typical
gouty attacks, and he had a few excoriations on his chest.
The remainder of the exam was unremarkable.

Multiple Laboratory Studies
Lab study
WBC
Neutrophils %
Monocytes %
Lymphocytes %
Eosinophils %
Basophils %
HgB 20.0
Hct
Platelets
Iron 243
TIBC 379
% Iron Saturation
Ferritin
Erythropoietin
B12
B12 binding capacity
Folate
LAP 132
Uric acid
AST 45
ALT 40
ABG on room air

Patient value
Reference range
15.0
4.0-11.0 B/L
69.4
40-73%
5.7
3-13%
22.2
20-44%
1.4
0-6%
1.3
0-3%
12.5-15.0 g/dL
60.0
36.0-46.0 g/dL
253
140-400 B/L
40-155 mcg/dL
250-400 mcg/dL
64
20-55%
436.9
12-300ng/mL
4.4
4.0-15.4 mU/mL
559
100-250 pg/mL
1986
1000-2000 pg/mL
3.4
>2ng/mL
11-95
9.2
3.4-7.0 mg/dL
2-50 u/L
2-60 u/L
7.44/ 30/ 109/ 96

Ultrasound studies showed normal kidneys,
splenomegaly, and fatty change of the liver. No spaceoccupying lesions or ductal dilatation was noted. The
blood flow and waveforms of the hepatic vein, portal vein,
and IVC were unremarkable. Chest x-ray was negative.
Based on the patient’s hemotolgical abnormalities on labs,
a bone marrow biopsy of the left iliac crest was performed.
Mild hypercellularity was seen, with increased megakaryocytes, normoblastic erythropoiesis, and myeloid
precursors in all stages, without a block in maturation.
Reticulin stain demonstrated foci of early fibrosis, while
Prussian blue staining identified increased iron stores with
rare ringed sideroblasts (See Figures B and C, Color Plates
page 19). After careful review, findings appeared
consistent with polycythemia vera. It was felt that the
patient was likely early in the course of disease, given the
larger than expected iron stores consistent with the
amount of erythropoiesis.

(Continued on next page)
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The patient was phlebotomized 3.5 units initially, and then
again another 3 units to keep his hematocrit less than 45%.
He tolerated these procedures without difficulty and was
scheduled for repeat blood work and future phlebotomies.
Discussion
The myeloproliferative disorders include polycythemia
vera, essential thrombocytosis, and myelofibrosis with
myeloid metaplasia. Chronic myelogenous leukemia is
often considered separately because of its known
chromosomal association: the Philadelphia chromosome.
Polycythemia vera (PV) demonstrates a clonal
proliferation of hematopoietic stem cells and is
characterized by an increased red blood cell mass. The
erythroid cells proliferate independently of erythropoietin
(EPO). Overproduction of all three cell lines can be seen.
PV is more common in males than females with a ratio
of 1.2:1. Epidemiological studies completed in
Rochester, Minnesota show an incidence of 2.3/100,000.
Median age at diagnosis is approximately 60 years. 1
Presenting signs and symptoms of PV are often
nonspecific and include headache, tinnitus, fatigue,
epigastric discomfort, hepatomegaly, splenomegaly
(75%), and facial plethora. Pruritus, especially after a hot
bath or shower, is typical. The exact etiology of this is
uncertain but is likely linked to histamine release or
prostaglandins. Erythromelalgia, burning sensations in
one’s hands or feet with concomitant pallor, cyanosis, or
erythema, in presence of palpable pulses, is also seen. This
is felt to be a microvascular complication of the disease.2
Episodes of thrombosis, like Budd Chiari syndrome, as
well as bleeding and peptic ulcer disease can be evident.
A prothrombotic latent phase of approximately two years
involving arteries and veins has been described.5 Increased
uric acid levels are often noted as well. 1
Typically, an increased hemoglobin/hematocrit is noted.
The hemoglobin is usually greater than 16.5 g/dL and
18.5 g/dL in women and men, respectively. A spurious
polycythemia can be noted when a patient is volume
depleted. This is often seen in patients on diuretic therapy
and reverts to normal with volume repletion. Once an
elevated hemoglobin is noted, decisions must be made to
determine whether it is a primary or secondary

polycythemia. Secondary polycythemia can be due to
hypoxia from cardiac or pulmonary disease, as well as from
high altitude. Smoking is another etiology of erythrocytosis. Renal disease should be excluded as an EPO
secreting tumor may be present. 2 If there is a decreased
MCV and iron studies, indicative of iron deficiency
anemia in the presence of a high normal hemoglobin,
some have advocated iron supplementation to see if an
erythrocytosis is unmasked. This would place the patient
at an increased risk of thrombosis and it is more prudent
to assume that the patient has a true erythrocytosis. 4
In the 1960s-1970s, the Polycythemia Vera Study Group
set forth diagnostic criteria. These criteria were made to
select patients for clinical trials. It included three major
and four minor criteria. The main criteria included
increased red cell mass (males >36mL/kg, females >
32mL/kg), normal hemoglobin oxygen saturation (>
92%), and splenomegaly. A leukocytosis >
12,000cell/uL, thrombocytosis >400,000cell/uL,
elevated leukocyte alkaline phosphatase > 100, and an
increased vitamin B12 or B12 binding capacity were
minor criteria.3 As leukocytosis may be secondary to
other etiologies, an ANC >10,000 has been used of late.
Recently, there has been a trend away from using these
criteria due to the number of false positive and negative
results. Rather than diagnostic criteria many clinicians
are using an algorithmic approach.
Once an elevated hemoglobin has been noted and the
diagnosis of PV is suspected, a full work-up should
ensue. In the past, an increased red blood cell mass was
needed for diagnosis. This test is not widely available and
is expensive. If the patient is early in the disease process
or has concomitant microcytic anemia, it may be falsely
negative, and if using hemoglobin measurements greater
than 2 standard deviations greater than the mean, the
test is typically positive. Therefore, in most cases, this
test is not ordered and a serum EPO level is measured.2
If it is high, etiologies of secondary polycythemia should
be further investigated. If it is normal or low, PV is
possible. In PV, it is typically low but may be low normal.
Many then proceed to a bone marrow biopsy. Bone
marrow biopsy in PV demonstrates hypercellularity,
increased megakaryocytes, decreased iron stores, and

(Continued on next page)
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mild reticulin fibrosis. If the diagnosis is still uncertain,
futher cytogenetic tests may be completed. For example,
a decreased expression of the TPO receptor by
megakaryoctes supports the diagnosis. 1 An endogenous
erythroid colony assay, not widely available, could be
done. This study determines if erythroid colonies
proliferate in the absence of EPO.2
The main treatment for PV continues to be phlebotomy.
The goal is to keep the hematocrit below 45% in males
and 42% in females. This is to avoid thrombotic
complications. Patients should be instructed to avoid
iron supplementation. In patients who are felt to be at
especially high risk for thrombosis, based on platelet
count, past medical and family history, chemotherapy
may be an option. Hydroxyurea, busulfan, alphainterferon, 32P, and anagrelide have been used. The
concern is adverse effects of the drugs including
leukemia.1 Alkylating agents especially are associated
with an increased risk of neoplasm. Phlebotomy alone is
associated with an increased risk of thrombosis and
fibrosis.5 A survey in 2002 by the American Society of
Hematology demonstrated that 69% of physicians used
phlebotomy as first line of treatment. Nearly 28% used
the combination of phlebotomy and hydroxyurea, and
only 10% employed the use of hydroxyurea alone.3
Erythromelagia seems to respond to low dose aspirin.
The pruritus often responds to aspirin, antihistamines,
and in some instances selective serotonin reuptake
inhibitors.1 Low dose aspirin (30-75 mg/day) may also
be beneficial in preventing thrombosis and is not
associated with the increased risk of bleeding seen at
higher dosages.5 Allopurinol is used in those with
symptomatic hyperuricemia.1

Previously, untreated PV had a life expectancy of 6 to 18
months after diagnosis but with current treatment
approaches it is felt to be greater than 15 years. The main
complications are those of thrombosis and progression
of the disease to myeloid metaplasia with myelofibrosis
(MMM) or acute myeloid leukemia. The most frequent
causes of death linked to thrombosis include myocardial
infarction, ischemic cerebrovascular events, and
thromboembolism. The risk of thrombosis increases with
age. There is debate over the percentage of patients who
progress to MMM.4 It is currently felt that about 10 years
after diagnosis, approximately 10% of patients will have
MMM. 1 This number increases with length of survival.4
In the same time frame, there is approximately a 5%
transformation rate to acute leukemia.1 Research to
explore other therapeutic options for PV is ongoing.
References
1. Tefferi, A. Polycythemia Vera: A Comprehensive Review
and Clinical Recommendations. Mayo Clinic Proceedings
2003; 78(2): 174-194.
2. Tefferi, A. Diagnosing Polycythemia Vera: A Paradigm
Shift. Mayo Clinic Proceedings 1999; 74(2): 159-162.
3. Streiff et al. The diagnosis and management of
polycythemia vera in the era since the Polycythemia Vera
Study Group: a survey of American Society of
Hematology members’ practice patterns. Blood 2002;
99(4): 1144-1149.
4. Pearson et al. A Polycythemia Vera Update: Diagnosis,
Pathobiology, and Treatment. American Society of
Hematology Education Program Book. Hematology 2000.
5. Gruppo Italiano Studio Policitemia. Polycythemia Vera:
The natural history of 1213 patients followed for 20 years.
Annals of Internal Medicine 1995; 123(9): 656-664.
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A Man With Diarrhea And Achalasia
Dan Valancius MD, PGY-3 Internal Medicine

A 78 y/o male with an extensive history of CAD s/p
multiple MIs and CABG surgery, presents with two and
one half weeks of diarrhea. About 9 weeks prior, he had
been diagnosed with achalasia, and was treated with a
botulinum toxin injection, with resolution of his
symptoms of dysphagia. He was also hospitalized a month
ago after experiencing chest pain, and subsequently ruled
in for a small non-ST elevation MI. He underwent
coronary catheterization at that time, and was found to
have severe multivessel disease unamenable to PTCA or
bypass surgery. Now, he presents with progressively
frequent “brown watery” diarrhea for the past couple of
weeks, reporting up to 20 episodes a day, occurring also
at night and causing episodes of fecal incontinence. He
denies blood in his stools, or recent antibiotic use.
Diarrhea is associated with abdominal cramping, and is
not relieved with Lomotil taken every 8 hours. During
this period, the patient also notes several episodes of nonbloody, non-bilious emesis, the last occurring one day
ago, with an inability to tolerate po intake and a 10 lb
weight loss over the two weeks. He denies recurrent
dysphagia, fevers or chills, recent travel, heat intolerance,
or palpitations. He had a routine screening colonoscopy
6 years ago that was reportedly ‘normal’.
Past medical history includes multivessel coronary artery
disease status post 3 vessel bypass surgery in 1998,
chronic renal insufficiency with a baseline Cr of 1.7, and
newly diagnosed achalasia.
His present medications include lisinopril, diltiazem,
metoprolol, isosorbide mononitrate, aspirin, atorvastatin,
clopidogrel, pantoprazole, and sublingual nitroglycerine
as needed He has no known drug allergies or food
intolerances.
Family history is significant for a father who died of an
unspecified ileitis, and a paternal uncle with Crohn’s
disease. The patient smoked 5-6 cigars a day for 45 years.
He lives with his wife at home and often babysits his
healthy 5 y/o grandson.
Vital signs include a temperature of 97.9 degrees,
respirations 12 per minute, 99% saturation on room air,
supine BP 90/50 and HR 68, and standing BP 80/50

and HR 68,. Physical examination reveals a thin male in
no acute distress. Dry mucus membranes are noted, with
flat neck veins, a normal cardiac exam, and lungs clear
to auscultation. He has normoactive bowel sounds, a
non-tender, non-distended abdomen without
organomegaly. On rectal exam, he was found to have
heme negative brown stool in the vault with good rectal
tone. There was no evidence of peripheral edema and he
was neurologically intact.
Laboratory tests obtained on admission are shown in
tables 1 and 2.
Table 1. Admission Hematology Labs
White cells (per mm3)
Differential count (%)
Neutrophils
Lymphocytes
Monocytes
Eosinophils
Basophils
Hemoglobin (g/dL)
Hematocrit (%)
Platelet (B/L)
ESR (mm/hr)
PTT (sec)
INR
PT (sec)

11,300
54
17
6
22 (0-6)
1
14
40.8
193
17 (0-15)
29
1.13
14.4

Table 2. Admission Blood Chemistry
Sodium (mmol/L)
Potassium (mmol/L)
Chloride (mmol/L)
Bicarbinate (mmol/L)
BUN (mg/dL)
Creatinine (mg/dL)
Total protein (g/dL)
Albumin (g/dL)
Total bilirubin (mg/dL)
Direct bilirubin (mg/dL)
Alk Phos (IU/L)
AST (IU/L)
ALT (IU/L)

133
4.6
101
22
60
3.5
5.8(6.0-8.5)
4.5
1.0
0.3
104
20
27

(Continued on next page)
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Table 3. Stool Studies
Sodium (mmol/L)
Potassium (mmol/L)
Chloride (mmol/L)
C.diff
Fecal leukocytes
Stool ova and parasite
Stool giardia antigen

88 (135-146)
42.2(3.5-5.0)
77(98-109)
Negative x3 sets
Negative x2
Negative x2
negative

Hospital Course
Given the patient’s recent hospitalization, he was initially
started on oral metronidazole for the possibility of
Clostridum difficile colitis, and rehydrated. Creatinine
corrected to baseline over the next several days. Stool
studies were performed, with results detailed in table 3.
Metronidazole and loperamide resulted in significant
improvement of diarrhea, with bowel movements
decreased to 6 episodes daily. When metronidazole was
discontinued after negative C diff specimens, the patient
again clinically worsened. A diagnostic flexible
sigmoidoscopy was performed, which was essentially
normal. Upper endoscopy for evaluation of the small
bowel was then done, which showed the esophagus was
mildly dilated, consistent with the patient’s history of
achalasia. Nonerosive gastritis was also visualized.
Multiple biopsies were taken of antrum and duodenum.
Pathology several days later revealed eosinophilic
infiltration consistent with a diagnosis of eosinophilic
gastroenteritis. H pylori stains were negative.
The patient was subsequently started on oral
prednisone, with rapid resolution of both his diarrhea
and peripheral eosinophilia.
Discussion
Eosinophilic gastroenteritis is an uncommon disease
characterized by eosinophilic infiltration of the gastrointestinal tract. Diagnosis of eosinophilic gastroenteritis
requires the following criteria: (i) presence of gastrointestinal symptoms, (ii) eosinophilic infiltration of one
or more areas of the GI tract on biopsy, (iii) organs
outside the GI tract must be free of eosinophilic
infiltration, and (iv) parasitic infestation must be
absent.1 A slight male predominance has been reported,
with patients typically presenting in the third through
fifth decades of life.1 Though any segment of the
gastrointestinal tract may be affected, the stomach or
small bowel are most commonly involved.1,2

Eosinophilic gastroenteritis is classified according to the
layer of bowel wall affected.3 Patients with mucosal layer
disease present with protein-losing enteropathy, fecal blood
loss, and malabsorption. Muscle layer disease may lead to
obstruction, while subserosal involvement leads to
eosinophilic ascites.3 However, clinical and pathologic
features may overlap, with involvement of multiple layers
of the gut wall.2 In one series, abdominal pain was the most
frequently recorded symptom (100%), followed by
diarrhea (62.5%), vomiting (62.5%), and nausea (50%).3
Of note, as seen in our reported patient, isolated esophageal
involvement may cause a variety of manometric
abnormalities, including achalasia.4 About half of patients
have a personal or family history of allergic disease, and
half report a history of food intolerance or allergy.2
Peripheral eosinophilia is found in about 80% of
patients, though the presence of peripheral eosinophilia
is not a diagnostic criterion.1,2 Iron deficiency anemia can
develop.1 The serum albumin level may be low in 2030% of cases, mostly with mucosal disease.1 The
erythrocyte sedimentation rate may be normal to
moderately elevated.1
Stool studies should be done to exclude parasitic
infestation. Charcot-Leyden crystals may be seen on a
stool wet mount examination.2 Though stool may be
positive for occult blood, this finding is variable.2 The
radiographic changes found in eosinophilic gastroenteritis are nonspecific, and in at least 40% of cases, are
completely absent.5
Endoscopic findings also vary, including prominent
mucosal folds, hyperemia, ulceration, or nodularity.6 The
distribution of disease tends to be patchy, and for this
reason, multiple biopsies (at least six) should be taken, if
eosinophilic gastroenteritis is suspected.1
Histologically, eosinophilic gastroenteritis is characterized
by an inflammatory cell infiltrate comprised almost
entirely of eosinophils.7 It should be noted, however, that
eosinophilic infiltration is the most consistent histologic
finding found on biopsy in gastroesophageal reflux as
well.8 In cases where there is a question whether
eosinophilic infiltration represents eosinophilic esophagitis
or gastroesophageal reflux,the location may be a clue, with
more proximal locations favoring eosinophilic esophagitis.2
Table 4 outlines some of the important clinical and
laboratory features of eosinophilic gastroenteritis.
(Continued on next page)
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Table 4. Features Consistent with Eosinophilic Gastroenteritis

Table 4. Differential Diagnosis for Eosinophilic Gastroenteritis

Mucosal layer disease
Pain, nausea, vomiting, diarrhea, weight loss
Iron deficiency anemia
Malabsorption
Protein-losing enteropathy
Muscle layer disease
Obstruction
Subserosal layer disease
Eosinophilic ascites
Peripheral eosinophilia 80%
Eosinophilic infiltration of GI tract on biopsy
Low serum albumin 20-30%
ESR normal to moderately increased
Negative stool studies for parasites
Stool positive for occult blood (variable)
Charcot-Leyden crystals on stool exam (unknown frequency)

Parasitic infections
Vasculities
Inflammatory bowel disease
Hypereosinophilic syndrome
Drugs
Cancer (specifically gastric adenocarcinoma)

Parasitic infections are characteristically associated with
peripheral eosinophilia and should be ruled out. The
hookworm A. caninum as well as the pinworm Enterobius
vermicularis may cause eosinophilic colitis.2 Giardia lamblia
can be associated with jejunal infiltration with eosinophils,
though peripheral eosinophilia is usually absent.2 The
consumption of raw fish may lead to infection with
Anisakis.2 Other parasites which may be considered include
T. stercoralis, Trichinella spiralis, and Schistosomiasis.
Various drugs including azathioprine, gemfibrozil,
carbamazepine or clofazimine may cause diarrhea and
peripheral eosinophilia.2 Vasculitic disorders may mimic
eosinophilic gastroenteritis, including Churg-Strauss
syndrome, typically seen in patients with a history of
asthma, and polyarteritis nodosa, typified by peripheral
eosinophilia in association with multisystem involvement
including the kidney, lung, nervous system or skin.2
Other diagnostic considerations may include Crohn’s
disease, cancer, and hypereosinophilic syndrome.
Histologic features should clearly separate Crohn’s disease
from eosinophilic gastroenteritis.2 Gastric infiltration of
eosinophilis may be striking in gastric adenocarcinoma,
though peripheral eosinophilia is unusual.2 In hypereosinophilic syndrome, persistent peripheral eosinophilia
is associated with infiltration of multiple organs including
bone marrow, heart, lung liver, spleen kidneys, skin, and
central nervous system.2 Table 4 outlines other disoders
which may mimic eosinophilic gastroenteritis
8

Steroids are the mainstay of therapy for eosinophilic
gastroenteritis, and clinical response is usually dramatic.1
In approximately 50% of cases, low dose prednisone
therapy may be required to maintain remission.2 Other
therapies, including sodium cromoglycate, have been
reported to be effective.2 In patients who have traveled
to, or live in areas that put them at high risk for parasitic
infection, a trial of antimicrobial therapy such as
mebendazole may be considered, prior to initiating
steroids, since parasitic infection may be difficult to rule
out.2 Once recognizably diagnosed, eosinophilic
gastroenteritis has a good prognosis without associated
risk of cancer.1
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Prevention of Central Venous Catheter-related Infections
Raghuram Mallya MD, PGY-3 Internal Medicine

The central venous catheter is a valuable tool in inpatient
medicine. However, with its use comes the risk of local
and systemic infections. Kluger et al estimated that
250,000 cases of central line-associated blood stream
infections occur annually. Mortality rates range from 1225% per infection.1 Therefore, it is essential that health
care providers take all necessary precautionary measures
to avoid infection. Guidelines have been published by the
Centers for Disease Control and Prevention to provide
an evidence-based medicine (EBM) approach for
avoiding central venous catheter-related infections.
Recommendations include proper skin cleansing, the use
of maximal sterile barriers, selection of the subclavian site,
avoiding routine replacement of central venous catheters,
and using antiseptic/antibiotic impregnated catheters.
Aseptic technique is the first step in infection prevention.
The patient’s skin must be properly disinfected, prior to
the insertion of any venous catheter. Typically, povidone
iodine is used for skin antisepsis. However, Maki et al
demonstrated a lower incidence of bacteremia with the
use of 2 % chlorhexidine gluconate, versus 10% povidoneiodine or 70% alcohol (0.5 versus 2.3 and 2.6 per 100
catheters, respectively).2 Furthermore, Chaiyakunapruk et
al performed a meta-analysis which showed a 50% overall
reduction in catheter-related blood stream infections with
the use of chlorhexidine.3
Once the skin has been properly disinfected, the
practitioner must take additional measures to maintain
sterile conditions. The use of sterile gloves and drapes
alone are not enough. A study done in 1994 by Raad et
al showed that using maximal sterile barrier precautions
(a cap, gown, sterile gown, sterile gloves and a large sterile
drape) substantially reduced catheter-related bloodstream
infections, as opposed to standard precautions with only
sterile gloves and small drapes.4
The site of the central venous catheter has also been
linked to infection. Collignon et al found that the lowest
rate of catheter colonization occurred with placement at
the subclavian site, and the highest rate with catheters at
the femoral site (15% vs 34%, respectively).5 Femoral
catheters have also been associated with a higher risk for
deep venous thrombosis (DVT). Therefore, from an
EBM standpoint, the subclavian vein is the preferred site

of insertion for infection control purposes. Note that all
factors must be taken into account when selecting a
catheter site in a given patient, including operator skill,
the potential for mechanical complication, patient
comfort, anatomic variables, and bleeding diatheses.
Once the central venous catheter has been placed using
proper aseptic technique, it should not be changed on a
scheduled basis. Cobb et al conducted a randomized
controlled trial where 160 patients underwent one of
four methods of catheter exchange: replacement every
three days by insertion at a new site (group 1); exchange
over a guidewire every three days (group 2); replacement
when clinically indicated by insertion at a new site
(group 3); exchange over a guidewire when clinically
indicated (group 4). The incidence rates of bloodstream
infection per 1000 days of catheter use were 3 in group
1, 6 in group 2, 2 in group 3, and 3 in group 4. Therefore
careful clinical inspection of that catheter site at least
every other day is recommended versus prophylactic
changes of catheter site.6 The exception to this is the
Swan-Ganz catheter, which should be removed within 35 days and replaced at a new site if further monitoring is
required. When changing a central venous catheter is
clinically indicated, options include changing over a
guidewire or insertion at a new site. For infection control
purposes, placement at a clean site is preferred. However,
this method is associated with a greater incidence of
mechanical complications.
Lastly, the type of catheter used has been shown to affect
the rate of infection. There is a higher incidence of
infectious complications with multi-lumen catheters.
Studies have also been done with antiseptic and
antibiotic impregnated catheters. A meta-analysis by
Veenstra et al showed a decrease in catheter colonization
and catheter-related bloodstream infections with
chlorhexidine/silver sulfadiazine-impregnated catheters,
versus non-impregnated catheters.7 Reductions in
bacteremia
have
also
been
noted
with
minocycline/rifampin-impregnated catheters.8 The
chlorhexidine/silver sulfadiazine impregnated catheters
were also more cost effective.9 Currently, the CDC
recommends implementing a comprehensive strategy to
lower the incidence of catheter related bloodstream

(Continued on next page)
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infections (CRBSI), including education of practitioners,
use of maximal barrier protection, and 2% chlorhexidine
for skin antisepsis. If the CRBSI rate remains above the
institutions goal despite these measures, then
antibiotic/antiseptic impregnated catheters should be
used in adult patients in whom the central venous
catheter is expected to remain in place for >5 days.
Central venous catheter infections remain a prevalent
problem in inpatient medicine. While risk of infection is
always present with indwelling lines, measures can be
taken to minimize this potentially fatal complication.
Proper aseptic technique with thorough skin preparation
and maximal barrier precautions, careful site selection,
and diligent clinical inspection of a catheter site can
drastically reduce infection risk and improve patient care.
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A Man with Dyspnea and Diffuse Abdominal Pain
Dominick Galluzzo MD, PGY-3 Internal Medicine

A 50 y/o male with a PMH significant for HIV/HCV
co-infection, and chronic renal insufficiency, presented
to the ED with a one week history of progressive dyspnea
and diffuse abdominal discomfort. He reported resting
shortness of breath without orthopnea, PND, or chest
pain. His abdominal pain was diffuse, and he denied
nausea, vomiting, increased abdominal girth or lower
extremity edema.

insufficiency) and anion gap of 5 (presumably related to
hypoalbuminemia). The presence of a delta anion gap of
8 suggested a true anion gap acidosis. A serum lactate
was subsequently measured, which was markedly
elevated at 68.6.

He was diagnosed with HIV 3 months earlier, following
an admission for septic arthritis. One month ago his
CD4+ count was 125 and his viral load 200,000 copies,
at which time he began antiretroviral therapy with
Combivir (zidovudine/lamivudine) and Sustiva (efavirez)
and prophylactic therapy with Bactrim. The patient
reported strict compliance with his medical regimen.

Diagnosis And Clinical Outcome
The patient was admitted with the diagnosis of lactic
acidosis, likely secondary to his nucleoside reverse
transcriptase inhibitor (NRTI) therapy with Combivir.
AST/ALT values peaked at 3621/721 respectively the
morning after admission. By withholding antiretroviral
therapy, the lactic acid level trended back to normal values
and the patient’s transaminases returned to his baseline.
He continued to improve symptomatically within about
1 week and had returned to his baseline functional status.

On admission his vitals were as follows: temperature 98.9
F, pulse 107 bpm, blood pressure 112/63, respirations
28/min with an oxygen saturation of 96% on room air.
The physical exam revealed a thin black male in
moderate discomfort, exhibiting Kussmaul breathing
with an otherwise clear lung exam. Abdominal exam
revealed normal bowel sounds and mild diffuse
tenderness, without rebound or guarding. There was no
evidence of JVD, lower extremity edema, or S3.

Discussion on NRTIs and Lactic Acidosis
The development of lactic acidosis is a very rare, but
often fatal, complication of therapy with nucleoside
analogues. The estimated incidence of this disorder is
only about 1-4 cases per 1000 person years; however it
carries a sobering mortality rate of about 50% 1. Though
an exact mechanism is yet to be clearly defined, it appears
to be related to the inhibition of mitochondrial DNA
polymerase and development of hepatic steatosis.

Laboratory data revealed: sodium 136, potassium 5.6,
chloride 112, bicarbonate 11, BUN 36, creatinine 2.6,
glucose 113; WBC 6.4, hemoglobin 9.1, and platelets
193; AST 306, ALT 77, alkaline phosphatase 567,
albumin 2.4. Arterial blood gas values were pH 7.33,
pCO2 22, PO2 154. Finally, chest x-ray demonstrated
clear lungs and EKG revealed normal sinus rhythm with
T wave inversions in V1- V6.

Perhaps of larger interest to clinicians is the ability to
identify important risk factors for the development of lactic
acidosis. Due to the rarity of this disorder, large-scale
studies are difficult to design to evaluate this question.
However, a series of case reports and cohort studies have
been published. Treatment with any of the NRTIs has been
associated with lactic acidosis; however the use of stavudine
and lamivudine appears to confer the greatest risk 2,3.
Another small cohort study suggests additional risk factors
may include creatinine clearance of <70 mL/min and a
nadir CD4+count of <200 cells/m3. 4 Finally, pregnancy
has also been targeted as a potential risk factor 5-7.

Discussion Of The Acid-Base Disorder
- A “Normal Gap” Lactic Acidosis?
Initial review of the arterial blood gas and chemistry
panel revealed a metabolic acidosis with an expected
respiratory compensation (calculated PCO2 by Winter’s
formula = 24+/-2). The calculated anion gap was 13,
leading us to conclude that the primary disorder was a
non-gap acidosis. However, prior lab studies were
available for this patient, which revealed a baseline
bicarbonate of 20 (presumably related to chronic renal

In conclusion, the development of lactic acidosis during
therapy with NRTIs is a rare but potentially lethal
complication. Thus, clinicians should maintain a high
level of clinical suspicion when HIV+ patients on such
therapy complain of GI distress, dyspnea or general
malaise,
particulary
in
the
setting
of
(Continued on next page)
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Skin biopsy of a discrete lesion shows a foci of multiple giant
multinucleated cells within the dermis layer. This finding is characteristic of herpes simplex, which systemically disseminated in this
immunocompetent patient, causing multiorgan failure. With
intravenous antiviral therapy, the patient made a full recovery.

This is a pedunculated jejunal polyp. Because the patient is
asymptomatic and the polyp is less than 15 mm in size, no
therapeutic intervention is recommended at this time. Patients
with PJS should be screened endoscopically with EGD,
colonoscopy, and small bowel evaluation at least every two years
after the age of 12.

D – Slide

A – Capsule Image

Submitted by Carl D. Mele, MD

B – Radiograph
A 3 x 2 cm type Ia choledochal cyst is visualized at the junction
of the common hepatic and common bile ducts (note the cystic
duct take-off from the choledochal cyst itself ). Although the
patient has minimal symptoms, the cyst needs to be surgically
excised because of an increased risk of cholangitis and
malignancy. This is a congenital abnormality seen more
commonly in women, with an incidence of roughly 1 in 15,000.
Submitted by Carl D. Mele, MD

C – Slide
Liver biopsy of the nodules shows microabscesses with fungal
elements on GMS (silver) stain. Note the extracellular beaded
fungal elements embedded in debris, surrounded by fibrosed
liver parenchyma.
Submitted by Jun Liu, MD
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Submitted by Aparna Mukherjee, MD

E – Radiograph
The diagnosis is chylothorax, which is characterized by pleural
fluid with a turbid or milky white appearance, secondary to high
lipid content (mostly triglycerides), that enters the pleural space
via disruption of the thoracic duct. Patients report gradual onset of
decreased exercise tolerance, dyspnea, fatigue, and a heavy feeling
in the chest. Fever and chest pain often do not occur, because of
the failure of chyle to produce an inflammatory response.
Malignancy is responsible for 45 percent of total cases and 63
percent of nontraumatic cases. Lymphoma is the single most
common cause of chlylothorax, but Castleman’s disease,
sarcoidosis, histoplasmosis, tuberculosis, lymphangiomyomatosis, multiple myeloma, and goiters are also associated with
this pathology. Surgical procedures account for most traumatic
cases of chylothorax.
The procedure shown above is a thoracic duct embolization.
The effustion can be seen at the apex of the left lung.
Radiographic dye is injected into a surgically exposed lymphatic
channel in the foot. After several minutes to hours, the dye
migrates to the cisterna chyle and into the thoracic duct. At this
point a needle is inserted into the thoracic duct and a glue-like
material is injected, essentially thrombosing the entire duct.
Submitted by Bryan Pukenas, MD

Answers to the Clinical Quiz at the end of this edition of Jefferson Forum

Don’t Peek!
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women for maternal health and interventions to reduce
perinatal HIV-1 transmission in the United Sates. August
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stavudine/lamivudine use, diminished creatinine
clearance, pregnancy and CD4 counts less than 200.
Furthermore the use of NRTIs should be immediately
held, once the diagnosis of lactic acidosis is considered.

4. Bonnet, M et al. Risk factors for lactic acidosis in HIVinfected patients treated with nucleoside reversetranscriptase inhibitors: a case-control study. Clin Infect
Dis 2003; 36:1324-1328.

References

5. Sarner, L, Fakoya A. Acute onset lactic acidosis and
pancreatitis in the third trimester of pregnancy in HIV-1
positive women taking antiretroviral medication. Sex
Transm Inf 2002; 78:58-59.

1. Ogedegbe, A et al. Hyperlactatemia syndromes associated
with HIV therapy. The Lancet Infect Dis 2003; 329-37.
(Continued from previous page)

Case Presentations

Abstract

A Male with Chills and Arthralgias
Lo-Ku Chiang MD, PGY-3 Internal Medicine and Ambrish Ojha MD, PGY-5 Infectious Diseases

A 53-year old man presented to the ED with complaints
of fevers and chills for 5 days. Two days prior, he started
having generalized arthralgias and a painfully numb left
index finger. Similar symptoms had also begun on his
left great toe (See Figures D and E, Color Plates page
19). The patient denied recent trauma, although he was
unsure if he had sustained an insect bite on the dorsal
aspect of his left hand 8 hours prior to the onset of
symptoms. Three sets of blood cultures obtained prior
to admission were positive for methacillin-sensitive
Staphylococcus aureus. The patient was treated with
intravenous nafcillin and gentamicin. A transesophageal
echocardiography was performed, which showed a friable
and perforated left coronary cusp of the aortic valve,
resulting in severe aortic insufficiency. The patient was
scheduled for emergent aortic valve replacement. It was
surmised that the initial site of infection was a badly
ulcerated blister located on the patient’s right great toe.

Discussion
There are numerous peripheral manifestations of
bacterial endocarditis. The classic peripheral manifestations are found in up to half of the cases, but the
prevalence has decreased in recent years. Janeway lesions
are painless erythematous, hemorrhagic, or pustular
lesions that are seen on the palms or soles and are often
associated with acute bacterial endocarditis. Oslers
nodes, which are tender, subcutaneous nodules often
located on the pulp of the digits typically seen with
subacute bacterial endocarditis. Other vasculitic
complications include major arterial emboli, septic
pulmonary infarcts, mycotic aneurym, conjunctival
petechiae and intracerebral hemorrhages. Immunologic
phenomena include glomerulonephritis, a positive
rheumatoid factor, Roth spots and superficial retinal
hemorrhages. These clinical findings are part of the
minor criteria in the Duke classification of diagnosing
bacterial endocarditis.
Frequently, the presentation of endocarditis is not clear
and a high level of clinical suspicion is essential in a
patient with fever and systemic symptoms suggestive of
infective endocarditis.
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A Man with Fevers and Chest Pain
Jigar Patel MD, PGY-3 Internal Medicine

A 42 y/o Hispanic man without significant medical
history presented to the ED with the complaint of
increasing left-sided chest pain. The patient reported that
symptoms began 4 days prior, when he developed a
severe headache. That night, he noted increasing chills
and sweats, with a fever measured at 103 degrees F. The
following morning, he developed left-sided chest pain
that he described as a pressure exacerbated by movement
and breathing. For the next several days, he reported
feeling worse with continuous chills and fever spikes up
to 105 degrees F, along with increased severity and
duration of his chest pain.
The patient mentioned that acetaminophen and overthe-counter analgesics did not relieve his symptoms.
With his chest pain, he also noted associated shortness
of breath with mild nausea. However, he denied
abdominal pain or changes in his bowel habits, and he
reported that his weight had been stable. He had never
had these symptoms before.
The patient’s past medical history was remarkable for a
trauma-related leg fracture in 1995 that was repaired by
open reduction and internal fixation. He also had oral
surgery in 2000 for severe periodontitis and subsequently
had to have a full mouth extraction.
He denied alcohol, tobacco or illicit drug use. He was
married for 18 years with 2 healthy children. He denied
any HIV risk factors. He also did not report any recent
travel or exposure to known sick individuals. He worked
at a surgical instrument manufacturing plant.
On admission, his vital signs were: blood pressure 99/62,
pulse 133, respirations 22, temperature 99.6 degrees F
and oxygenation saturation 96% on room air. He
appeared to be acutely ill, although alert and cooperative
to exam. His pupils were equal and reactive with normal
extraocular movements. He had complete maxillary and
mandibular dentures and dry mucus membranes.
Cardiac exam revealed a normal S1 and S2, regular rate
without appreciable murmurs. Notable findings on lung
exam were bibasilar rales. His abdomen was benign, and
he did not have evidence of rash or lesions.

An electrocardiogram revealed sinus tachycardia with a
rate of 127. Chest x-ray showed bilateral interstitial
opacities involving middle and lower lung fields suggestive
of an atypical infectious process. There was no
cardiomegaly, pulmonary edema or pleural effusions.
Laboratory data indicated normal chemistries, a white
blood cell count of 14.5 with 84% neutrophils, and 4%
bands. Platelets were decreased at 47,000. Cardiac markers
were all normal. The INR was 1.23 with a PTT of 36.
A presumptive diagnosis of community-acquired versus
atypical pneumonia was made and the patient was
rehydrated and started on iv moxifloxacin. The night of
admission, the patient’s clinical status quickly
deteriorated with increasing oxygen requirements up to
5 liters via nasal cannula, with oxygen saturations in the
low 90% range. Complete blood count drawn the next
morning revealed a white blood cell count of 16.1 and
platelets at 35,000. Physical exam the next day was
noteworthy for a new systolic ejection murmur heard
best at the apex with radiation to the axilla. A thorough
skin exam revealed characteristic splinter hemorrhages
and Janeway lesions on the palmer surface of hands and
the soles of the feet (See Figures F and G, Color Plates
page 19). A formal fundoscopic exam revealed Roth’s
spots in both eyes. A transthoracic echocardiogram was
done, which showed a 1.6 cm x 1.4 cm mass attached to
the lateral base of the posterior leaflet of the mitral valve.
The mass was noted to be smooth with no projections.
It was felt to be rather unusual and atypical for a
vegetation. The ejection fraction was normal. Admission
blood cultures came back positive for gram positive cocci
in clusters. A DIC panel showed increased D-dimer,
decreased fibrinogen and elevated INR.
The clinical picture was most consistent with acute
bacterial endocarditis. The patient was started
empirically on vancomycin and gentamycin.
He continued to do poorly with higher oxygen
requirements to maintain saturations greater than 90%.
A portable chest x-ray showed frank pulmonary edema.
The patient was urgently transferred to the cardiac care
unit with presumed mitral valve failure, secondary to the
vegetation. His blood pressures were controlled with
nipride and hydralazine and he was aggressively diuresed
(Continued on next page)
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with iv furosemide. The antibiotic regimen was
broadened to include Rifampin. Unfortunately, he did
not improve clinically. Multiple blood cultures continued
to show Staphylococcus aureus, despite several days of
antibiotic therapy. The decision was made, in
consultation with Cardiac Surgery, to take the patient to
the operating room for emergent mitral valve
replacement. Intraoperativly, a 2 cm x 2 cm friable
vegetation was noted at the posterior leaflet of the mitral
valve. There was also a large abscess cavity burrowing
into the annulus destroying about 2/3 of the posterior
annulus. Histopathology revealed Staph aureus colonies
embedded within the vegetation (See Figures H-J, Color
Plates page 19). Postoperatively, the patient did well for
the next 48 hours, and was deemed stable for transfer
out of the cardiothoracic critical care unit. Shortly
thereafter, he again developed temperature spikes, with
persistently positive blood cultures despite re-initiation
of antibiotics. On post-op day 7, he had an acute episode
of shortness of breath with evidence of pulmonary
edema, requiring reintubation. It was determined that
his prosthetic mitral valve had been reinfected and was
failing. Despite all heroic efforts, the patient ultimately
succumbed to sepsis.
Discussion
Infective endocarditis (IE) is defined as an infection
which can produce vegetations on the endocardium,
including valves, septae, or mural endocardium. IE is
almost invariably fatal, if untreated. An estimated 10,000
to 15,000 new cases of IE are diagnosed in the USA each
year, with male to female ratios ranging from 2:1 to as
high as 9:1. IE can be broadly classified into native valve
and prosthetic valve infection, with subdivisions within
each category based on the microorganism (further classifications can also be made based on the nature of the
infected valve; this will be expounded further in treatment
options). Although native valve endocarditis can be
caused by almost any kind of bacteria, the three most
common include streptococci, staphylococci and
enterococci. The HACEK organisms (Haemophilus,
Actinobacillus, Cardiobacterium, Eikenella, and Kingella)
are oral flora that cause a subacute presentation and are
very difficult to grow on media, hence the term ‘culture
negative’ endocarditis. In patients who have indwelling

catheters and/or are immunocompromised, fungal IE can
occur with Candidia and Aspergillus species. Prosthetic
valves predispose to endocarditis. In one study, IE of
prosthetic valves accounted for 10-20 percent of cases. In
addition to valves, intravascular sutures and pacemaker
wires can also become foci of infection. Early onset
prosthetic valve endocarditis (less than 60 days after
surgery) is usually secondary to intraoperative
contamination
or
perioperative
bacteremia.
Approximately half of all cases are caused by
staphylococci, with S. epidermidis more frequent than
S.aureus. Gram negative rods can account for up to 15
percent and fungi up to 10 percent of early cases. When
late endocarditis occurs (onset > 60 days) the organism is
usually a streptococcus species (about 40% of cases). Early
prosthetic IE often runs a fulminant course, with valvular
dysfunction and valve dehiscence. Although late
prosthetic IE can progress similarly, more often the
clinical course resembles non-prosthetic IE with
streptococcus and is luckily not as catastrophic. There are
several known risk factors for the development of IE,
including injection drug use, prosthetic heart valves, and
structural heart disease. Other factors have been
postulated to increase the risk of IE. These form the
theoretical basis for antimicrobial prophylaxis prior to
planned invasive procedures in certain individuals.
Several criteria have been developed for the diagnosis of
IE. It should be noted that the diagnosis is ultimately
based on the clinical picture and compulsory adherence
to set criteria is usually not necessary. That being said,
the Modified Duke Criteria is one of the most commonly
used set of guidelines, using a schema of major and minor
criteria. Major criteria include positive blood cultures for
organisms that cause IE, evidence of endocardial
involvement, suggestive echocardiogram findings, and
new valvular regurgitation. Minor criteria are many and
include: history of intravenous drug use or structural
heart disease, fevers >100.4 degrees F, vascular stigmata
such as Janeway lesions, or septic emboli, immunologic
phenomena such as Osler’s nodes or glomerulonephritis,
and microbiological evidence. A definite diagnosis is
made on either pathological OR clinical criteria. Clinical
criteria usually requires 2 major criteria or 1 major and 3
minor or 5 minor criteria. Possible IE is defined as 1
major and 1 minor OR 3 minor.
(Continued on next page)
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The treatment of IE is dependent on the valve, as well as
the suspected organism. The following table summarizes
the different regimens available to treat IE. (Although
only one choice is presented, it should be noted that
there are alternative antibiotics that can be used for each
type of infection.)

Type of Infection

Antibiotic Choice

Native Valve IE
from PCN sensitive
Streptococcus
Native Valve IE
from PCN resistant
Streptococcus
Standard Therapy
for Endocarditis
due to Enterococcus
Native Valve IE due
to Methicillin Sensitive
Staphylococcus

PCN G 12-18 million
U/24hr OR Ceftriaxone
2gm IV q24h
Vancomycin 30mg/kg
per 24h IV in 2 divided
doses
Ampicillin 12g/24h IV
WITH Gentamycin
1g/kg IV every 8h
Nafcillin/Oxacillin
2gm IV every 4h
WITH Gentamycin
1mg/kg IV every 8h
Vancomycin 30mg/kg
per 24h IV WITH
Rifampin 300mg orally
every 8h WITH
Gentamycin 1mg/kg
IV every 8h
Nafcillin/Oxacillin 2g
IV every 4h WITH
Rifampin 300mg orally
every 8h WITH
Gentamycin 1mg/kg
IV every 8h
Ceftriaxone 2g IV
every 24h

Prosthetic Valve IE
with Methicillin
Resistant
Staphylococcus

Prosthetic Valve IE
with Methicillin
Sensitive
Staphylococcus

Therapy due
to HACEK
Microorganism

Length of
Treatment
4 weeks

1. Bansal, RC. Infective endocarditis. Med Clin North Am
1995; 79:1205.
2. Bayer AS, Clin Infect Dis 1993 Sep;17(3):313-20.
3. Fowler, VG, Durack, DT. Infective endocarditis. Curr
Opin Cardiol 1994; 9:389.
4. Li, JS, Sexton, DJ, Mick, N, et al. Proposed modifications
to the duke criteria for the diagnosis of infective
endocarditis. Clin Infect Dis 2000; 30:633.
5. Molavi, A. Endocarditis: recognition, management, and
prophylaxis. Cardiovasc Clin 1993; 23:139.

4 weeks

4–6
weeks
4–6
weeks

Greater
than 6
weeks

Greater
than 6
weeks

4 weeks

From Wilson, WR, Karchmer, AW, Dajani, AS, et al, JAMA 1995; 274:1706
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Isolated Abducens Nerve Palsy Secondary To Varicella Zoster In A Patient With HIV
Ellen B. Lunenfeld MD, PGY-2 Internal Medicine; John A. Walker MD

Varicella Zoster, the recrudescence of the dormant
varicella virus, occurs more often in older patients and
in those who are immunocompromised. Herpes Zoster
ophthalmicus (HZO) is the second most common
manifestation of the disease, second only to thoracic and
lumbar zoster.1 HZO is estimated to account for 10% to
25% of cases.2,3 HZO can lead to a number of ocular
complications, including proptosis, disciform keratitis,
internal ophthalmoplegia, bilateral retinal detachments,
Argyll-Robertson pupil, and progressive outer retinal
neuropathy (PORN).1-4
Cranial nerve palsies are a known complication of
varicella zoster, most often involving the third cranial
nerve, although they can include the third, fourth, fifth
or sixth nerves, or any combination of these.4 Extraocular
muscle paralysis, while well-documented, accounts for a
small percentage of cases of ocular complications of
herpes zoster ophthamicus.3 Among these, isolated sixth
nerve palsies are an infrequent manifestation and have
not previously been reported in a patient with HIV. We
report such a case.
Case report
A 45 year-old female with a 3-year history of untreated
HIV infection was admitted to the hospital after she
noted a painful vesicular rash on her face, accompanied
by a high fever and decreased vision. Approximately two
months prior to admission, she noted a painful rash in a
dermatomal distribution on left side of her abdomen,
extending from mid-axillary line to her back at
approximately the level of her umbilicus. She was treated
with oral acyclovir with resolution of the lesions.
Approximately one month prior to admission she
developed a similar rash on her face. The skin lesions were
bilateral, in a mandibular distribution on her left side and
on a maxillary distribution on her right side. She noted
associated symptoms of malaise, high fever, and decreased
vision. The patient was hospitalized for management with
intravenous ((IV) acyclovir. After 14 days of treatment,
she was discharged with instructions to follow up at this
institution’s Retina- Vitreous service. There, she was
diagnosed with progressive outer retinal neuropathy
(PORN) and was begun on oral acyclovir. One week later,
the patient’s retinal disease was found to have worsened
and she was admitted for more aggressive treatment.

On admission she was noted to have resolving skin
lesions consistent with varicella zoster, along with
bilateral involvement of her retina with progressive outer
retinal neuropathy (PORN) and a right lateral rectus
palsy. All other cranial nerves were intact. Her CD4
count and viral load were 21 cells/mL and 331,486
copies/mL, respectively. The patient was begun on a
regimen of IV foscarnet, 1920 mg Q8 hr for a total of
14 days. On the 7th day of treatment she was begun on
IV ganciclovir at 5 mg/kg. She was discharged on day 18
on continued ganciclovir treatment at 5 mg/kg/d. While
her PORN had improved somewhat during the hospital
admission, her right lateral rectus paralysis persisted.
Comment
Herpes zoster ophthalmicus is a common manifestation
of varicella zoster disease with a distinct set of
complications. It results when the latent virus, present in
the trigeminal ganglia, is reactivated. Because of the
numerous delicate structures in the vicinity of the
infection, many clinically significant complications can
occur.1 Extraocular muscle paralysis can manifest with
both primary varicella and zoster.2,5 Reports have varied
with regard to prevalence of extraocular muscle paralysis
among patients with HZO. Marsh et al. reviewed a series
of 69 patients and found an incidence of 58 cases of
extraocular muscle paralysis among 146 cases of herpes
zoster ophthalmicus. In this group of patients, 42%
experienced CN III involvement, 44% with CN VI
involvement, and 30% with CN IV involvement.
Isolated CN VI nerve paralysis accounted for 25% of
cases.6 Ragozzino et al. noted 6 cases of motor deficits
among 55 cases of herpes zoster ophthalmicus, none of
which involved the extraocular muscles.3 Other reports
have demonstrated an 11% to 29% incidence of
extraocular muscle paralysis among patients with HZO.7
The order of prevalence is greatest for the third nerve
and least for the trochlear nerve.6
There have been documented cases of abducens nerve
paralysis in patients with herpes zoster ophthalmicus.
Goldsmith documented a case of a lateral rectus muscle
paralysis which resolved within 6 months.4 Nemet et al
documented a case of an isolated lateral rectus muscle
paralysis in a case of primary varicella.5 Archambault et

(Continued on next page)
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al reported six cases of herpes zoster ophthalmoplegia,
two of which were cases of sixth nerve paralysis, neither
one of which occurred in isolation.7 Ramsell reported a
case in which the second, third fourth, fifth and sixth
nerves were all involved.8 A MEDLINE review of the
literature from 1966 revealed no previously reported case
of HZO-related CN VI palsy associated with HIV
infection.
The exact cause of HZO-related cranial nerve palsy is
unknown. There is limited documented pathology to
allow definitive analysis of tissue damage.7 Perineural and
perivascular inflammation occur as a consequence of
herpes zoster ophthalmicus, and may account for some
of the sequelae. Theories explaining possible causes of
the involved neural tissue include direct damage caused
by the virus, an allergic response to the viral infection,
and an occlusive vasculitis triggered by the virus.6
Treatment of extraocular paralysis secondary to varicella
zoster usually involves management with antivirals, such
as acyclovir or famicyclovir. The natural history of the
disease is slow and spontaneous resolution in the
majority of patients, usually occurring between six weeks
to eighteen months.4 There is no documentation to
indicate whether patients with acquired immune
deficiency syndrome have a longer recovery time, or if in
fact their extraocular muscle paralysis is unlikely to
resolve at all. Certainly cases of herpes zoster in HIV
patients have been shown to be more severe and
debilitating, presumably relating to the immunologic
status of the patient.10 It is unknown, therefore, whether
treatment should be directed differently towards these
patients. Two months after discharge, our patient
reported improved vision, but her right abducens nerve
paralysis still had not resolved.
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A Woman with Extreme Fatigue
Christopher DiMaio MD, Chief Medical Resident, Internal Medicine

A 23 year old female presented to her primary care
provider’s office complaining of extreme fatigue over the
past few weeks.

recreational drug use. The patient has one tattoo, dating
about 8 years. She is sexually active in a monogamous
relationship and her partner uses condoms.

The patient’s past medical history is significant for stage
2B Hodgkin’s lymphoma, diagnosed 2 years ago. The
patient received 4 cycles of chemotherapy with ABVD,
as well as multiple rounds of radiation therapy. Upon
completion of treatment, her Hodgkin’s was considered
cured. The patient did develop hypothyroidism
secondary to the radiation treatments, and requires
permanent thyroid hormone replacement.

Her vitals on presentation follow: blood pressure 126/78
mm Hg, heart rate 82, respirations 16, and temperature
98.6. The patient appears her stated age, and is in no
apparent distress. Sclerae are anicteric, and conjunctivae
pink. No oropharyngeal exudates or apthous ulcers are
seen, and there is no evidence of cervical, axillary,
supraclavicular, or inguinal lymphadenopathy. Thyroid
is not enlarged or tender. Cardiac exam is normal and
her lungs are clear. Her abdomen is mildly obese,
nontender and nondistended, with normoactive bowel
sounds. There is no hepatosplenomegaly. No peripheral
edema or joint abnormalities are appreciated, and she is
neurologically intact.

Four weeks prior to presentation, the patient noted the
onset of her symptoms. She stated that she has been
taking a lot of naps throughout the day, which is unusual
for her. She denied fevers, chills, night sweats, changes
in weight, or viral illnesses over this time.
At her primary care physician’s office, the patient was
found to have elevated LFT’s. (Table 1)
Table 1. Outpatient Laboratory Values

Total protein
Albumin
Total bilirubin
Direct bilirubin
AST
ALT
Alkaline phosphatase

4 weeks prior
to admission
6.2
3.2
1.2
149
182

Dermatologic exam is notable for generalized jaundice.
Admission laboratory data is listed in Table 2.
Table 2. Laboratory Values Upon Admission

1 week prior
to admission
2.9
2.6
152
198
158

The patient was referred to a gastroenterologist for
evaluation and work-up. She began to develop visible
jaundice, generalized pruritus, and dark urine, without
fevers, abdominal pain, nausea, vomiting, or pale stools.
She was subsequently hospitalized for further work-up.
On review of systems, the patient denies chest pain,
shortness of breath, lymphadenopathy, diarrhea,
constipation, myalgias, joint pains, or changes in her
menstrual cycle. Her medications include levothyroxine
and Depo-provera injections for birth control. She has
used tobacco for the past 8 years, less than one-half pack
of cigarettes per day, and consumes about 5 beers over 1
weekend per month. She denies any IVDA or

Na
K
Cl
CO2
BUN
Cr
Wbc
Hgb
MCV
Plts
Total protein
Albumin
Total bilirubin
Direct bilirubin
AST
ALT
Alkaline
phosphatase
PT
INR
PTT
Hep A IgM/IgG

140
3.5
109
27
10
.9
5.0
9.4*
109
124
5.6
2.5
10.9
4.3
95
30

Hep B surface
antigen
Hep B core
antibody
Hep B surface
antibody
Hep C
antibody
AMA
ANA
Ceruloplasmin
Iron
TIBC
Iron saturation
Ferritin
Reticulocytes
Absolute
reticulocyte count
33
LDH
21.0
B12
1.82
Folate
43
Haptoglobin
Negative
TSH
*Hgb was 14.4 approximately 1 year ago.

Negative
Negative
Negative
Negative
Negative
Negative
6.0
122
127
96%
1030
15.1
110.9
189
1242
13.4
< 6.0
3.69

(Continued on next page)
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Isolated Abducens Nerve Palsy Secondary To Varicella Zoster In A Patient With HIV
Ellen B. Lunenfeld MD, PGY-2 Internal Medicine; John A. Walker MD

Varicella Zoster, the recrudescence of the dormant
varicella virus, occurs more often in older patients and
in those who are immunocompromised. Herpes Zoster
ophthalmicus (HZO) is the second most common
manifestation of the disease, second only to thoracic and
lumbar zoster.1 HZO is estimated to account for 10% to
25% of cases.2,3 HZO can lead to a number of ocular
complications, including proptosis, disciform keratitis,
internal ophthalmoplegia, bilateral retinal detachments,
Argyll-Robertson pupil, and progressive outer retinal
neuropathy (PORN).1-4
Cranial nerve palsies are a known complication of
varicella zoster, most often involving the third cranial
nerve, although they can include the third, fourth, fifth
or sixth nerves, or any combination of these.4 Extraocular
muscle paralysis, while well-documented, accounts for a
small percentage of cases of ocular complications of
herpes zoster ophthamicus.3 Among these, isolated sixth
nerve palsies are an infrequent manifestation and have
not previously been reported in a patient with HIV. We
report such a case.
Case report
A 45 year-old female with a 3-year history of untreated
HIV infection was admitted to the hospital after she
noted a painful vesicular rash on her face, accompanied
by a high fever and decreased vision. Approximately two
months prior to admission, she noted a painful rash in a
dermatomal distribution on left side of her abdomen,
extending from mid-axillary line to her back at
approximately the level of her umbilicus. She was treated
with oral acyclovir with resolution of the lesions.
Approximately one month prior to admission she
developed a similar rash on her face. The skin lesions were
bilateral, in a mandibular distribution on her left side and
on a maxillary distribution on her right side. She noted
associated symptoms of malaise, high fever, and decreased
vision. The patient was hospitalized for management with
intravenous ((IV) acyclovir. After 14 days of treatment,
she was discharged with instructions to follow up at this
institution’s Retina- Vitreous service. There, she was
diagnosed with progressive outer retinal neuropathy
(PORN) and was begun on oral acyclovir. One week later,
the patient’s retinal disease was found to have worsened
and she was admitted for more aggressive treatment.

On admission she was noted to have resolving skin
lesions consistent with varicella zoster, along with
bilateral involvement of her retina with progressive outer
retinal neuropathy (PORN) and a right lateral rectus
palsy. All other cranial nerves were intact. Her CD4
count and viral load were 21 cells/mL and 331,486
copies/mL, respectively. The patient was begun on a
regimen of IV foscarnet, 1920 mg Q8 hr for a total of
14 days. On the 7th day of treatment she was begun on
IV ganciclovir at 5 mg/kg. She was discharged on day 18
on continued ganciclovir treatment at 5 mg/kg/d. While
her PORN had improved somewhat during the hospital
admission, her right lateral rectus paralysis persisted.
Comment
Herpes zoster ophthalmicus is a common manifestation
of varicella zoster disease with a distinct set of
complications. It results when the latent virus, present in
the trigeminal ganglia, is reactivated. Because of the
numerous delicate structures in the vicinity of the
infection, many clinically significant complications can
occur.1 Extraocular muscle paralysis can manifest with
both primary varicella and zoster.2,5 Reports have varied
with regard to prevalence of extraocular muscle paralysis
among patients with HZO. Marsh et al. reviewed a series
of 69 patients and found an incidence of 58 cases of
extraocular muscle paralysis among 146 cases of herpes
zoster ophthalmicus. In this group of patients, 42%
experienced CN III involvement, 44% with CN VI
involvement, and 30% with CN IV involvement.
Isolated CN VI nerve paralysis accounted for 25% of
cases.6 Ragozzino et al. noted 6 cases of motor deficits
among 55 cases of herpes zoster ophthalmicus, none of
which involved the extraocular muscles.3 Other reports
have demonstrated an 11% to 29% incidence of
extraocular muscle paralysis among patients with HZO.7
The order of prevalence is greatest for the third nerve
and least for the trochlear nerve.6
There have been documented cases of abducens nerve
paralysis in patients with herpes zoster ophthalmicus.
Goldsmith documented a case of a lateral rectus muscle
paralysis which resolved within 6 months.4 Nemet et
paralysis in a case of primary varicella.5 Archambault et
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Quantitative tests of copper are useful in suggesting a
diagnosis. Serum free copper levels are typically elevated.
Urinary copper levels may also be elevated. It should be
noted, however, that any disease with hepatocellular
necrosis can result in elevated urinary copper levels. Liver
biopsy with quantitative analysis for copper is considered
the gold standard, but in patients with coagulopathy or
ascites, this modality may not be an option. Hepatic
copper concentrations are typically greater than 250
mcg/gm (dry weight) and can approach 3000 mcg/gm.
Elevated hepatic copper content can be elevated in
neonates and young children, as well as patients with
chronic cholestasis or copper overload.
Liver biopsy allows for quantitative analysis of copper,
and assessment of the extent of organ involvement.
Pathology can demonstrate changes anywhere along the
spectrum of steatosis to cirrhosis. Analysis of DNA for
mutations can also play a role in diagnosis, while also
identifying presymptomatic siblings of patients.
The goal of treatment in Wilson’s disease is to reduce the
total body amount of copper. Copper-rich foods such as
organ meats, chocolate, nuts, shellfish, and mushrooms,
should be eliminated from the diet. Instituting therapy
as early as possible is critical in avoiding long-term
complications of the disease.
First-line treatment is with D-penicillamine. This agent
acts as a copper chelator and increases urinary copper
excretion. Its effects can be seen within weeks to months
of initiation of therapy. Typical starting dose is at 250
mg a day, with titration to 1000-1250 mg a day. There
are numerous reports of acute hemolysis or neurologic
deterioration shortly after initiation of therapy,
particularly in those patients with neurologic symptoms.
D-penicillamine is associated with a large number side
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effect profile, including rashes, leukopenia, thrombocytopenia, nephritic syndrome, and a lupus-like reaction.
There is a 30% intolerance rate.
Trientene (triethylene tetramine dihydrochloride) is
another copper chelating agent that can be used as firstline therapy in those patients with allergies or
intolerance to D-penicillamine. It has a more favorable
side effect profile and is not associated with the
potential worsening of neurological symptoms. It has
been associated with sideroblastic anemia and colitis,
upon cessation. The typical dose is 500 mg three times
a day. Oral zinc is a newer treatment modality. Zinc
interferes with the absorption of copper from the
gastrointestinal tract and increased the amount of
copper excreted in stool. Other treatment options
include ammonium tetrathiomolybdate, an antioxidant
which inhibits gut absorption of copper by binding
copper-albumin complexes.
Screening for Wilson’s disease should be conducted in all
siblings of affected individuals, as well as those relatives
with a history of consanguinity. A complete physical
examination should be done with slit lamp ophthalmologic exam, along with liver function testing, and
determination of serum ceruloplasmin and copper levels.
Family members should be re-evaluated every 5-10 years.
References
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Training Residents in ACLS/Code Response Using a Computerized Medical Simulator:
Improving Resident Comfort and Preparedness
Elisabeth Dial MD*, Henry Schairer MD+, Steven Silver MD**, Jennifer Claves MD++, David Gardiner MD+++,
John Caruso MD++, Salvatore Mangione MD***, and Gregory C. Kane MD***

Internal Medicine residents are responsible for leading the
code response team at most teaching hospitals, yet many
graduating interns (PGY1s) may feel unprepared to run
codes. Currently, the only formal training for house staff
is the two-day American Heart Association’s Advanced
Cardiac Life Support (ACLS) course, generally required at
the beginning of internship, with recertification necessary
every two years. This course does not address leadership
skills or a resident’s self-reported sense of comfort with
leading a code team within a teaching hospital. Prior
investigations have highlighted the deterioration in
knowledge of important ACLS protocols, with knowledge
levels at or near ACLS training levels within 6 months.1,2
Schwid and Sivarajan showed that the use of computerized
ACLS simulator on CD-ROM improves retention of the
guidelines better than textbook review alone.3 Others have
shown that refresher courses can enhance performance in
a mock resuscitation setting, with improvements
maintained, in part, over several months.4 The use of more
life-like simulation training has recently come into favor,
through a variety of commercially available medical
simulators. We designed an ACLS training program with
such a medical simulator for interns preparing for their
PGY2 year, namely those residents about to assume
responsibility for leadership of the code team. Prior to the
simulation training sessions, we collected baseline data
regarding interns’ experiences in code situations and
comfort with the anticipated transition to leading the code
team, as they advance to the PGY2 year of training.
Our investigation involved the use of a computerized
Medical Simulator (MedSim‘) to better prepare house
staff to lead a code response team. We believed that such
practical training was lacking, while certainly important
for housestaff about to transition to a leadership role in
running resuscitation efforts in our institution. The goal
of our project was to give our interns some practical
experience in a life-like simulation of three ACLS
scenarios, while assessing improvements in their selfreported level of comfort with the role of team leader
and preparedness for dealing with future code situations.
*Fellow in Pulmonary and Critical Care Medicine, ** Fellow in Cardiology
++Clinical Assistant Professor, Division of General Internal Medicine
***Associate Professor of Medicine, Division of Pulmonary and Critical Care
All in the Department of Medicine, Jefferson Medical College, Philadelphia, PA
+Attending Nephrologist, Lehigh Valley Medical Center, Allentown, Pennsylvania
+++Fellow in Infectious Diseases, Cornell University, New York, New York
Corresponding author: Gregory C. Kane, MD Jefferson Medical College, Department of Medicine

Methods
Thomas Jefferson University Hospital is a 550-bed
teaching hospital with 37 categorical residents in each
year of training and 6 preliminary medicine residents.
The code blue team consists of two upper year residents
(PGY2 or PGY3) assigned to lead the resuscitation effort
and two interns to provide the actual care. Interns
complete 8 blocks of inpatient assignments with time on
the code team. PGY2’s are assigned to rotations with
overnight coverage and leadership of codes during 8
blocks, while PGY3’s are assigned to only 2 blocks. All
PGY1s were asked to participate in simulation training
of code situations during the last quarter of the academic
year (April/May 2000), prior to the start of their PGY2
year. Interns participated in teams of three and were
asked to complete a questionnaire (QRE) and sign
consent before taking part in the training exercise. A
follow-up QRE was administered again at the start of
their PGY2 year, after the interns had completed
training. All responses were confidential and did not have
any personal identifying information. A follow-up QRE
was completed by residents continuing in the categorical
internal medicine residency program.
MedSim‘ was designed to run several simulated Code
Blue scenarios that were developed by the residency
program leadership. The simulator consists of a
computerized mannequin with synthesized heart and
lung sounds, palpable pulses, pupillary responses, a
functional airway, and IV access. The cardiac rhythm,
BP, and oxygen saturation are displayed on an ICU
monitor. Medications given by trainees through an
electronic stop-cock lead to anticipated physiologic
responses. Each resident performed one standard
scenario while the other two residents assisted. The
scenarios, unknown to the trainees, included tension
pneumothorax with pulseless electrical activity,
symptomatic bradycardia, and ventricular fibrillation. A
primary resident was assigned as code leader. The other
residents were assistants, charged with following the code
leader’s instructions, including airway intubation and
ventilation, CPR, and medication administration. For
each of the three scenarios, the residents would rotate
their responsibilities. Each scenario had a different
(Continued on next page)
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outcome. All sessions were videotaped so that actual
performance could be reviewed. After all three scenarios
were completed, the residents underwent a debriefing
with a Chief Medical Resident or faculty member. These
sessions included review of videotapes, review of critical
assessments and decision-making of the team leader, and
discussion of the correct course of action according to
established ACLS protocols.
The QRE used a standard 5-point Likert scale to
measured residents’ comfort level leading a code team,
familiarity with ACLS protocols, and sense of
preparedness to run resuscitation efforts. We also
collected data regarding the intern’s experience with
codes over the first 9 months of their PGY1 year of
training. Statistical analysis was performed on a PC
microcomputer using the SPSS statistical package (SPSS
Inc., Chicago, Illinois). Analysis consisted of chi-square
tests to relate dichotomous and nominal variables. Paired
t-tests were used for pre- and post- intervention
comparison on the several scale measures. Data
dispersion was expressed as one standard deviation and
significance set at a level of 95% or greater (P < .05).
Results
Forty-one interns completed the simulation training and
pre-QRE. Thirty-six of them completed the post-QRE
at the start of their PGY2 year. Two prelimary medicine
interns opted not to participate because of career interests
that did not include direct patient care. One categorical
resident missed the simulation training because of
vacation. All participating residents indicated that they
were currently certified in ACLS (confirmed by residency
program records). On average, the interns had attended
between 6 –10 codes during the preceding 9 months of
training (options for response included 1-5, 6-10,11-15,
etc). Only 4 of 41 (10%) were given an opportunity to
lead the resuscitation effort under the guidance of their
senior resident prior to the simulation exercise. The 4
interns who indicated that they had led a code, had only
done so one time each.
Prior to the intervention, trainees felt uneasy leading the
code team. Only 7/41 (17%) interns said they felt
“comfortable” running a code.

The simulated training program significantly increased
house staff sense of comfort and preparedness in running
codes. We observed improvement in their sense of
comfort in leading the Code Blue team (1 to 5 scale, with
5 as highest): 2.61 + 0.90 in the pre-intervention vs. 3.25
+ 0.87 post-intervention questionnaire (p = .003). We
also observed an increase in their sense of preparedness:
2.67 + 0.79 pre- vs. 4.03 + 0.97 post-intervention (p <
.001). Residents were enthusiastic about the training,
and nearly all (33/36, 92%) requested a follow-up
simulator session. Figure 1 shows the pre and post
intervention comparisons of the resident’s response to
the question “I am prepared to lead the Code Team”.
Discussion
The survival of hospitalized patients with critical
arrhythmias is clearly linked to the physician’s correct
treatment of the potentially deadly arrhythmia,
combined with availability of equipment and
coordination of care of the resuscitation team.5,6 Medical
simulation offers a realistic model to train house staff to
coordinate and lead a code team, while offering practical
exposure to common code situations.
At our institution, we found that interns approaching
the completion of their PGY1 year did not feel prepared
to run the code team, despite certification in ACLS. Few
had actual experience leading the code team as interns
and the number of codes attended was quite low (not
more than 10 resuscitation efforts). We found that house
staff comfort and sense of preparedness was enhanced
through lifelike training with a medical simulator and
mock scenarios with formal post-simulation debriefing.
Interns were overwhelmingly eager to undergo further
simulated training.
Our study, based on an educational intervention, did not
involve a control group. However, it is unlikely that such
an increase in housestaff confidence could have occurred
for other reasons. First, our data indicate that individual
intern experience with code blue situations was infrequent,
less than once per 4-week block. Thus, few interns would
have had further significant experience during the last few
blocks of their internship. Moreover, we do not require
our interns to recertify in ACLS at the end of internship
since their certificates are valid for two (2) years. At our
(Continued on next page)
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Resident Response to Question: I am Prepared to Lead Code Team?
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institution, the majority of inpatient night call and responsibility for leading codes occurs during the PGY2 year
prior to required recertification. While requiring ACLS
training annually would represent an alternate educational
strategy, more formal simulation with a group is the only
way to address team leadership skills- a major focus of our
simulations and debriefing sessions.
Since we report only on improvements in self-reported
measures of comfort and preparedness, the impact of our
findings does not extend to knowledge or performance.
Arguably, performance would be the ultimate standard
to judge such an intervention. Similar practical training,
but using a CD-ROM based format, combined with
expert debriefing or follow-up has been associated with
improvements in knowledge of ACLS protocols.3 The
advantage, however, of a true simulated training program
such as ours is threefold. In our simulations, interns
gained experience in leading a resuscitation team, worked
with the necessary equipment utilized in an actual
hospital resuscitation, and performed the important
manual skills required in codes, including airway control
and ventilation, chest compression, and needle
decompression of pneumothorax. Faculty or Chief
Residents observed the performance and provided direct
expert feedback regarding performance of critical aspects
of the resuscitation. Moreover, the use of videotape
enhanced the reliability and objectivity of the debriefing.7

We have found that at our institution, graduating
medical interns’ sense of comfort with leading the code
team is lacking. We have shown that comfort and sense
of preparedness can be enhanced through a program of
simulation training with expert feedback. Future work
will be required to see whether improvements in comfort
level or sense or preparedness correlate with increased
measures of knowledge or actual outcomes. The
availability of new technology in simulation training
affords a novel and ethical approach to training
housestaff that may yield benefits for hospitalized
patients who suffer an arrest.
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A Man with Shortness of Breath and Bloating
Matthew E. Levy MD, PGY-3 Internal Medicine

The patient is a 61-year-old male with a past medical
history of hypertension and insulin-dependent diabetes
mellitus presented to the ED with new onset shortness
of breath. He reported a three week progression of
dyspnea after one flight of stairs, from a normal baseline.
The patient also noticed 2 pillow orthopnea and
increased urinary frequency and urgency. He denied
fevers, chills, chest pain, palpitations or productive
cough. Symptoms began when he ran out of his oral
medications three weeks prior to admission (furosemide,
enalapril, digoxin, metoprolol, spironolactone, aspirin).
Family history was positive for alcoholic cirrhosis. Social
history was positive for occasional tobacco and alcohol
usage. Review of systems was also significant for a 2 to 3
month history of abdominal fullness and q3 day bowel
movements. Upon further review, the patient stated he
had a distended abdomen earlier, as an adult, that had
somewhat disappeared until recently. He denied
decreased oral intake, nausea, emesis, reflux, abdominal
pain, diarrhea, melena or hematochezia.
Physical exam revealed an obese African-American male
in no distress. Vital signs were pertinent for a resting
tachycardia at 128 beats per minute and a blood pressure
of 149/93. He had mild jugular venous distension and
tachycardia with frequent ectopic heart sounds. Lung
exam showed bibasilar crackles higher in the left lung
field. His abdomen was massively distended with a
rounded appearance, and dull to percussion throughout.
Bowel sounds were loudest in the right flank area. There
was no pain on palpation, rebound or guarding, and
shifting dullness or a fluid wave could not be elicited. His
extremities had 1+ pitting edema bilaterally to the knees.
Labs including serum chemistry, blood count, liver
function panel, PT and PTT, and cardiac enzymes were
all within normal ranges. ECG revealed sinus tachycardia
with multiple premature ventricular conductions and a
left bundle branch block, while chest x-ray was notable
for cardiomegaly and bilateral pulmonary vascular
congestion, consistent with heart failure.
The patient was admitted with a diagnosis of heart
failure, exacerbated by medication non-compliance. He
was restarted on his medications and ruled out for

Figure 1.

myocardial infarction. An echocardiogram showed global
hypo- to akinesis with an ejection fraction of
approximately 15%. His symptoms improved with
diuresis and he was asymptomatic by the end of his
hospital admission. However, the size of his abdomen
did not decrease, despite a negative fluid balance. An
ultrasound of his abdomen was performed to evaluate
for possible ascites secondary to heart failure. No ascites
was seen. Instead, a large cystic space-occupying lesion
was appreciated, involving most of the pelvis and
abdomen, with mass effect on the left kidney causing
moderate to severe left hydronephrosis (Fig 1).
Computer tomography confirmed the cystic mass that
measured 32 x 25 x 30 centimeters. (Figs 2-3). The
massive size of the lesion prevented identification of an
exact origin. Surgery was consulted for resection and
tissue diagnosis. An uncomplicated open laparotomy was
performed, which located the mass beneath the
mesentery of the colon with the left ureter draped over
it. There was no obvious connection to any of the
surrounding organs. Due to the size of the mass, it could
not be entirely excised, so it was first aspirated, with the
removal of 12,000 ccs of serous fluid, and then resected.
Pathology was consistent with benign mesothelial cyst.
No further workup was required and the patient was
discharged home in stable condition.

(Continued on next page)
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Figure 2.

Discussion
Mesenteric cysts are very rare benign fluid-filled tumors.
They account for only 1 in 100,000 acute adult hospital
admissions.1 They’re more commonly found in the
pediatric population (1 in 20,000 pediatric admissions).2
This is probably due to the more rapid progression of
symptoms in children, with a greater ratio of cystic
volume to intraabdominal volume). The Italian
anatomist Benineni reported the first mesenteric cyst in
1507 from an autopsy of an 8-year-old boy.3 P.J. Tallaux
performed the first successful resection of a mesenteric
cyst in 1850.4 Since then 750 to 1000 cases have been
reported in the literature.5-6
Figure 3.
(Continued on next page)

27

Case Presentations

(Continued from previous page)

Most mesenteric cysts in adults are asymptomatic. Over
40% are diagnosed incidentally during unrelated
surgeries.5 Others are found during routine physical or
radiological examinations. Physical examination may
show a distended abdomen mobile in the transverse plane
only, as opposed to mobile in all directions with omental
cysts.6 The most common symptoms are abdominal pain
with distension, anorexia, nausea, vomiting, and malaise.
Pain can be caused by infection or torsion of the cyst,
hemorrhage into the cyst, mesenteric stretching from the
cyst, or compression of surrounding structures causing
obstructions.7 Occasionally cysts will cause mesenteric
volvulus or herniations.5-6
Classification of mesenteric cysts used to be variable and
inconsistently applied, lacking pathologic correlation. In
1986, Ros et al collected 41 cases of mesenteric and
omental cysts and retrospectively classified them using
histology and imaging criteria. Five types of mesenteric
cysts were identified. These include lymphangiomas
(endothelial lining), enteric duplication cysts (enteric and
double-muscle lining), enteric cysts (enteric mucosa
only), mesothelial cysts, and non-pancreatic pseudocysts
that have a fibrous wall but no lining.8 Other nonmesenteric cysts include cystic mesotheliomas, cystic
spindle cell tumors, cystic teratomas, and cysts
originating from abdominal or retroperitoneal organs.9
Lymphangiomas are usually large, thin-walled, multiloculated cystic masses, formed from small bowel
lymphatic tissue that congenitally does not communicate
with lymphatic vessels. They are almost always seen in
childhood or adolescents.12 Lymphangiomas are often
attached to bowel wall and are more likely to cause partial
bowel obstructions.1,8 Ultrasound shows lymphangiomas
as multi-septated cysts that can be anechoic or contain
fluid-filled levels caused by debris.8,10 CT scans show a
cystic mass with attenuation (Hounsfield units) ranging
from water (serous contents) to fat (chylous contents).11
Enteric duplication cysts are thick-walled, unilocular cysts
with predominantly serous contents. These cysts probably
were once attached to normal bowel, but separated and
migrated into the mesentery. Their composition
“duplicates” that of the normal enteric wall. On histologic
examination, all layers of bowel are seen, including

mucosa, circular and longitudinal muscle layers, and
mesenteric plexus. Ultrasound shows a thick-walled,
anechoic cyst that internally resembles small bowel. CT
scan reveals the thick wall with serous fluid attenuation.8-9
Enteric cysts are thin-walled, unilocular cysts lined with
gastric mucosa only, lacking the muscle layers of an
enteric duplication cyst. They are formed from small
bowel or colonic diverticuli that migrate into the
mesentery. Ultrasound shows a hypoechoic mass with
occasional septations. CT scan shows a fluid-filled mass
without an identifiable wall and attenuation consistent
with serous contents.8-9
Mesothelial cysts are thin-walled, unilocular cysts lined
with mesothelial cells. They are thought to arise from
incomplete fusion of mesothelial layers during
development, and are found in mediastinum
(pericardial, pleural), omentum, and retroperitoneal
areas (splenic). Ultrasound shows an anechoic mass with
acoustic enhancement. They appear similar to enteric
cysts on CT scan.8-9
Non-pancreatic pseudocysts, like their pancreatic
namesakes, arise from local trauma or inflammation.
They are thought to be the results of a hematoma or
abscess that did not resorb. Pathologically they are thickwalled and septated, with hemorrhagic or purulent
contents. Ultrasound shows a thick-walled mass with
echogenic debris. CT scan shows a mass that may have a
fluid-fluid level differentiating blood from pus.8-9
Other masses in the abdominal cavity can mimic
mesenteric cysts. Cystic mesotheliomas are an
intermediate formation, between an adenomatoid tumor
and a malignant peritoneal mesothelioma. These benign
tumors are usually found in middle-aged women. They
are usually large and multicystic, and tend to reoccur
locally after resection.13 Spindle cell tumors, otherwise
known
as
gastrointestinal
leiomyomas
or
leiomyosarcomas, can occasionally undergo necrosis.
This causes liquification and hemorrhage into the center
of the neoplasm, creating an appearance similar to
mesenteric cysts on imaging. Ultrasound and CT scan
will show a complex cystic mass with a lot of internal
debris.14 Mesenteric teratomas, usually seen in children,
(Continued on next page)
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have cystic components and resemble mesenteric cysts
on physical exam. However, imaging studies will pick up
calcifications and accumulations of fat, that do not
appear in mesenteric cysts.15
Treatment
Mesenteric cysts very rarely resolve spontaneously and
surgical resection is most often required. Drainage of cysts
are not recommended, because they tend to reaccumulate
quickly. Marsupialisation of cysts are also not performed,
since they increase infection risk from a persistently
draining sinus. Complete resection of the cyst usually
prevents recurrence. This may require the removal of a
bowel segment, if the cyst cannot be separated cleanly, as
is the case with lymphangiomas.7 Recently, laparoscopy
has been used for identification and removal of mesenteric
cysts. Like other minimally invasive surgeries,
laparoscopic excision of mesenteric cysts significantly
reduces hospital duration and complication rates.
Mesothelial cysts are usually easier to remove, due to their
loose attachments to surrounding tissues.16 However, our
patient’s cyst was too large and too close to other vital
structures to be safely removed by laparoscopy.
Conclusion
Because of their relative rarity, mesenteric cysts are not
commonly considered by most primary care physicians
evaluating patients with abdominal complaints. Certainly
in cases of appreciable abdominal distention, when
physical examination is not consistent with ascites, a workup to rule out mesenteric cyst pathology could be
warranted. Ultrasound should be the first imaging
performed because of its ease of use and identification of
internal components of the cyst. CT scan and MRI can
delineate physical nature and relationship to adjacent
structures and should be performed prior to surgery. . New
approaches such as laparoscopic removal make mesenteric
cysts easy to cure. A definitive diagnosis can only be made
after surgical resection and histologic examination.
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A Woman with Headache and Chest Pain
Theresa Pondok MD, PGY-3 Internal Medicine

A 34 y/o woman, with a past medical history significant
for asthma, newly diagnosed hypertension, and migraines,
presented to the emergency department with complaints
of sudden onset chest pain. She was an active young
woman, who up until the day of admission, had been able
to run several miles without chest pain or shortness of
breath. Symptoms began the morning of admission, when
the patient reported that she developed a migraine
heachache, with typical right-sided temporal pain. After
administering an injection of Sumatriptan, her headache
resolved. Soon thereafter, she noted 5/10 substernal chest
pressure occurring suddenly at rest, without radiation to
her arms or jaw. It was not associated with nausea,
vomiting, diaphoresis or shortness of breath. The patient
stated that she had never experienced this type of pain
before, which alarmed her enough to come to the
hospital. One sublingual nitroglycerin, given in the ED,
complete relieved her symptoms.
The patient’s medical history included hypertension,
asthma, Raynaud’s phenomena, and migraine headaches.
Hypertension was recently diagnosed, and well
controlled off medications with a strict regimen of diet
and exercise. Her asthma was stable with very occasional
use of an albuterol metered dose inhaler, and she stated
that she had never been intubated or required hospitalization for an exacerbation. Her Raynaud’s symptoms
occured in her fingertips intermittently during the winter
months for the past several years. Migraine headaches
were diagnosed 2 years prior, and she had been tried on
several different abortive therapies without success. The
Sumatriptan had just recently been prescribed, and this
instance represented her first use.
The patient had no surgical history. She denied alcohol,
tobacco, or intravenous drug abuse. She lived at home
with her husband and four children. Both parents were
still alive, her father with atrial fibrillation and her
mother with hypertension. There was no family history
of sudden death or coronary artery disease. The patient
took no regularly prescribed medications, only prn
albuterol MDI and sumatriptan injections. Her allergies
included aspirin and shellfish, both of which exacerbate
her asthma symptoms. Review of systems was positive
only for the chest pain described above, occasional
palpitations and migraine headaches.

On physical examination the patient was afebrile with a
pulse of 112, respirations of 20, blood pressure of
111/66, and O2 saturation of 100% on 3 liters nasal
cannula. She was alert and oriented, in no acute distress.
Her oropharynx was clear, and heart regular with a
normal S1 and S2, and no audible murmurs, gallops, or
rubs. There was no detectable jugular venous distention.
Lungs were clear, and her abdomen soft, nondistended,
and non-tender. No peripheral edema was appreciated.
Laboratory data is shown in Table 1.
Table 1. Outpatient Laboratory Values
WBC
Hgb
PLT
Sodium
Potassium
Bicarbonate
BUN
Creatinine
Glucose
Total cholesterol
LDL
HDL
TG
CK
Troponin

8.0
15.9
228
138
4.1
25
9
0.8
189
193
113
50
79
321
1.9

The admission chest film showed clear lungs. The ECG,
however, revealed sinus rhythm with ST elevations in
leads II, III, and aVF, as well as ST depressions in the
anterior leads. An echo showed normal chamber sizes,
with distal lateral and mid to distal posterior wall
hypokinesis.
Hospital Course
The patient was admitted to the medical CCU for
management of an ST elevation myocardial infarction,
presumed to be secondary to coronary artery vasospasm.
The vasospasm was attributed to her recent use of
Sumatriptan. She was started on intravenous
nitroglycerin for relief of ongoing chest pain. A
continuous infusion of diltiazem was also started for
control of the vasospasm. Given the patient’s allergy to
aspirin, clopidogrel was initiated. Cardiac enzymes were
(Continued on next page)
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followed and the troponin I peaked at 27 ng/mL. The
patient continued to have episodic chest pain during her
stay in the CCU and consequently four days after her
admission, the patient underwent cardiac catheterization.
Catheterization showed luminal irregularities in the left
main, left anterior descending, left circumflex and right
coronary arteries. The second obtuse marginal, however,
showed 99% occlusion. The left ventriculogram revealed
posterolateral akinesis. Given the tortuosity of the vessel,
the OM2 lesion was not stented. The location of the
occlusion, however, did correspond with the area of
akinesis. It was thought that the patient had underlying
occlusion of the OM2, with superimposed vasospasm
secondary to use of Sumatriptan, and this precipitated
her acute myocardial infarction. The final decision was
to optimize medical management with clopidogrel,
diltiazem and a statin.
Coronary Vasospasm
Coronary vasospasm has also been referred to as
printzmetal or variant angina. Prinzmetal originally
described it in 1959 as a “temporary increased tonus” in
areas of high-grade coronary artery occlusion. Vasospasm
is a syndrome of cardiac pain secondary to myocardial
ischemia. The spasm itself can occur in normal or diseased
vessels and usually occurs within one centimeter of an
atherosclerotic plaque. The resultant ischemia will appear
as ST elevations on ECG, and this can typically be
reversed with nitroglycerine or calcium channel blockers.
The patients suffering coronary vasospasm are commonly
younger than those who present with other forms of
angina. They often lack the cardiovascular risk factors
typically associated with heart disease. As in the above
case, these patients often have other systemic signs and
symptoms of vasospasm, including Raynaud’s
phenomenon and migraine headaches. Interestingly, there
appears to be an increased incidence of symptoms in the
hours between midnight and early morning. The most
common cause of mortality associated with vasospasm
involves arrhythmias, including ventricular tachycardia.
Although the precise mechanisms have not been clearly
defined, there are some circulating theories to explain
the underlying pathogenesis of coronary vasospasm. One
hypothesis involves the autonomic nervous system. It has

been shown that both acetylcholine and methacholine
can precipitate vasospasm, thus inferring that the
parasympathetic nervous system may play a significant
role in the pathogenesis. The discovery that atropine and
alpha-receptor blockers cay prevent such spasm also
supports this theory. In fact, sympathetic denervation
(plexectomy) may be therapeutic in refractory patients.
Endothelial dysfunction may also play a role in
pathogenesis. Decreased levels of the endogenous
vasodilator nitric oxide, and increased levels of the
vasoconstrictor endothelin have been shown to impair
coronary dilatation. These compounds may play an
integral role in coronary vasospasm. Finally, patients with
areas of diffuse intimal thickening of the coronary
vasculature may also be at risk for spasm. With
underlying coronary artery disease, episodic vasospasm
alters preexisting plaques, leading to intimal disruption
and penetration of macrophages or aggregation of
platelets. Consequently, vasospasm may contribute to
vascular instability in these patients.
Sumatriptan, a serotonin (5-hydroxytryptamine [5-HT])
receptor agonist, causes vasoactive constriction of cerebral
vascular beds, making it useful as an abortive therapy for
migraine headaches. However, it has also been shown to
exhibit vasoactive activity in the systemic, coronary, and
pulmonic vascular beds. Three to five percent of patients
experience chest tightness, heaviness, pressure, or pain
after its administration. Occasionally, the chest pressure
or pain radiates to the left arm and hand, imitating angina
pectoris. ECG evidence of myocardial ischemia, however,
is rare. Recently, Welch reported that while over 3 million
migraine attacks have been treated with sumatriptan,
there have only been 4 reported patients with myocardial
ischemia due to coronary vasospasm, 1 of whom also had
cardiac arrhythmia. All four patients had underlying
cardiovascular disease. Sumatriptan has a mild
constrictive effect on coronary arteries. MacIntyre et al
found 10 patients undergoing diagnostic coronary
angiography who had a 14 percent reduction in the
diameter of the coronary arteries. Based on such evidence
and more recent case reports, sumatriptan is
contraindicated in patients with coronary artery disease
or vasospastic angina.

(Continued on next page)
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The typical ECG findings in patients with variant
angina are transient ST elevations associated with chest
pain, that then return to baseline with resolution of
symptoms. Cardiac catheterization plays a major role in
diagnosis. In patients presenting with the typical signs
and symptoms of variant angina, including nonexertional chest pain and ST elevations, angiography
may reveal normal vessels or, as in this case, a proximal
fixed obstruction in one or more of the coronary
arteries. It is in this latter group of patients that
vasospasm should be suspected. Two provocative tests
can help confirm this condition. The most sensitive and
specific test involves injection of intravenous
ergonavine, a vasoconstrictor, during catheterization.
The test is positive if drug administration replicates
symptoms or ECG findings. The effects should be
reversed with intracoronary nitroglycerine. Ergonavine
can also be used in conjunction with echocardiography.
Wall motion abnormalities after injection indicate a
positive test. Hyperventilation is a less sensitive test that
can also be performed during coronary catheterization.
The patient is instructed to hyperventilate for six
minutes and if acute ST changes are seen on ECG,
coronary vasospasm is inferred.
The image below shows cardiac catheterization with
hyperventilation-induced vasospasm of the proximal left
circumflex artery that resolved with the administration
of intracoronary nitroglycerine and diltiazem.
As with all types of coronary artery disease, risk factor
modification is essential. Cessation of smoking must be
enforced. Medical management includes lipid-lowering
medications, and calcium channel blockers or nitrates to
maintain coronary vasodilatory effects. Medical
treatment has shown favorable responses in female
patients and patients with ST-segment elevation during
selective spasm provocation tests. However, patients with
either a longer history of episodic chest pain or a history
of diffuse spasms do not improve with medical treatment
alone. Nonselective beta-blockers should be avoided, as
they may exacerbate vasospasm. Angioplasty is helpful if
there is a discrete area of occlusion, however its utility is
limited by the fact that many patients have multivessel
spasms. It has been recommended that calcium channel
blockers be continued after percutaneous revascularization for this very reason. In refractory patients, surgical
denervation with plexectomy may be an option.
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Case Presentations

An Unresponsive Woman Found Down
Murliya Gowda MD, PGY-3 Internal Medicine

A middle-aged unidentified female presented by fire
rescue to the emergency department after being found
unconscious in the snow. Her identity, familiar contacts,
and medical history were not known, but the patient was
presumed to be homeless.
On examination, the patient was found to have a core
body temperature of 75 F, an accucheck of 75, a
palpable systolic blood pressure of 60, heart rate of 39,
and shallow but spontaneous respirations. Pulse oximetry
was not obtainable secondary to her cold peripheral
extremities. In general, she was a thin disheveled female
dressed in multiple layers of clothes with damp boots,
and unresponsive to voice and tactile stimulus. The
patient had a dry oropharynx, anicteric sclera, but equal
and reactive pupils bilaterally. There was no evidence of
facial droop, jugular venous distension, or thyromegaly.
Her heart rate was slow but regular and there were no
audible murmurs. Lung exam revealed mostly clear
breath sounds, although decreased at the bases. Abdomen
was nontender and soft, with mild to moderate
distention and no organomegaly. Extremities were cold,
with severe sloughing of the skin over both feet and
ankles (trench foot and wet gangrene). Dorsalis pedis
pulses were intact by Dopplers. Neurological exam
revealed symmetric reflexes throughout with downgoing
plantar reflexes. She was immediately intubated for
airway protection and started on warmed intravenous
fluids, with warming blankets and warmed oxygen. She
was taken to the CCU for further monitoring and care.
Laboratory data revealed a WBC 6,000/ml3, hemoglobin
9.5 grams/dL, and 154,000 platelets. Coagulation profile
was abnormal with a PTT of 60, PT of 27.7, and INR
of 2.42. Urinalysis was significant for 4+ blood and 20
RBCs. A post-intubation arterial blood gas revealed a
serum pH of 7.45, pCO2 of 34, PO2 of 150 and 100 %
oxygen saturation. BUN was elevated at 36 with a
normal creatinine, and both blood alcohol and urine
drug screens were negative. Amylase, lipase, and
chemistries were normal. Chest x-ray revealed a normal
cardiomediastinal silhouette and no consolidation. Head
CT on admission showed no acute intracranial
abnormalities. Echocardiogram showed normal right and
left ventricular function, no pericardial effusion and trace
mitral regurgitation, tricuspid regurgitation and mild

pulmonary regurgitation. ECG showed sinus bradycardia
with a heart rate of 44, borderline intraventricular
conduction delay, prolonged QT interval, and Osborne
waves (J waves).
The patient was later identified as a 55 year-old homeless
female with past medical history significant for
schizophrenia, HIV, alcohol and tobacco abuse. The
patient was treated for severe hypothermia compounded
by MSSA bacteremia, sepsis, frostbite and wet gangrene
of the lower extremities, eventually requiring bilateral
below the knee amputations.
Brief Discussion
Approximately 700 people die in the United States each
year as a result of hypothermia. Risk factors include
homelessness, mental illness, older age, and alcohol and
drug addiction. Hypothermia is a core body temperature
less than 35 C (95 F). It can be additionally
categorized into mild hypothermia (32 C to 35 C or
90 F to 95 F), moderate hypothermia (28 C to 32 C
or 82 F to 90 F), and severe hypothermia (below
28 C or 82 F). At these temperatures, the systems
responsible for thermoregulation begin to fail.
Temperature regulation includes the balance between
heat production and loss. Heat is generated through
various cellular mechanism and is lost through
evaporation, radiation, conduction (transfer of heat to
another object) or convection (transfer of heat to air
currents). Temperature is regulated in the nuclei of the
preoptic anterior hypothalamus. Activation of
thermostats in the nuclei and peripheral cold receptors
initiate compensatory mechanisms, which eventually
leads to progressive depression of metabolism in each
organ system. In cold temperatures, the hypothalamus
stimulates heat production through shivering and
(Continued on next page)
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increases catecholamine, thyroid and adrenal activity.
Other compensatory mechanisms include vasoconstriction, which reduces heat loss by decreasing flow to
peripheral tissues. As metabolism in each organ system
slows, complications such as cardiac arrhythmias,
confusion, lethargy, hypoventilation, pulmonary edema,
muscle rigidity, metabolic derangements, and bleeding
diatheses, including DIC, can ensue.
Cold exposure is the most obvious cause of hypothermia,
but there are also many other conditions that can
exacerbate
or
precipitate
it.
Altered
pituitary/adrenal/thyroid axes can predispose, along with
hypoglycemia, sepsis, pancreatitis, uremia, and
neurological diseases. Illicit drugs or iatrogenic
medications can also alter body temperature fairly rapidly.
Medical approach for hypothermic patients primarily
focuses on airway protection, volume resuscitation,
careful monitoring of core body temperature, rewarming
techniques, and management of complications.
Endotracheal intubation is important in these patients
for airway protection, particularly in those with altered
mental status or a diminished cough reflex. Many develop
bronchorrhea with copious secretions, progressing to
frank pulmonary edema in some patients. Volume
resuscitation and pressor support are also important
elements in the management of hypothermic patients. As
core temperature rises, peripheral vasodilatation occurs,
leading to profound hypotension. Aggressive intravenous
hydration with warmed saline is crucial.
Hypotension can contribute to cardiac arrhythmias,
which can be refractory to conventional therapies.
Specifically, the bradyarrhythmias are typically
unresponsive to atropine and pacing is not indicated,
unless they persist after adequate rewarming. Classic
ECG findings show a sinus bradycardia with elevation of
the J-point (J or Osborne wave), representing distortion
of membrane repolarization. Ventricular arrhythmias
occur when core temperature is less than 82 to 90 F
(28 to 32 C). At these temperatures, the myocardium
becomes more susceptible to hypoxia, movement, and
hypovolemia. Caution must be taken not to jostle the
patient, as sudden movement can predispose them to
instantaneous arrhythmias. Often, ventricular

arrhythmias are treatment-refractory until core body
temperature has returned to normal. Standard ACLS
protocol is quickly initiated (defibrillation and
appropriate pharmacological agents); if initially
unsuccessful, rewarming techniques with CPR must be
instituted first, and after core body temperature has
reached 86 F to 90 F (30 C to 32 C), defibrillation
should be reattempted. In some studies, ventricular
arrhythmias in animal models have shown a response to
bretylium, which has even been used prophylactically at
some institutions. Life-supporting measures are
continued, unless the body is completely frozen and chest
compressions cannot be performed adequately, or there
is ice in the airways. There have been case reports
describing resuscitation efforts lasting several hours, until
the patient has been sufficiently rewarmed.
Monitoring core body temperature is a crucial element
in the management of hypothermic patients. The goal is
to increase core body temperature 1 to 2 degrees per
hour, and temperature should be monitored at more than
one site. Standard thermometers can give readings as low
as 93 F, and in these situations cannot reliably be used.
It should also be noted that rectal and bladder probes
have temperature readings that tend to lag behind true
core body temperature, while esophageal temperature
probes can be falsely elevated due to inhalation of
warmed air. Rewarming techniques include intrinsic heat
production (shivering), removal of wet clothing, and the
use of heating blankets and pads/insulation. Active
internal warming techniques, including pleural,
peritoneal, and bladder irrigation with warm saline,
continuous veno-veno or arterio-veno hemodialysis, and
cardiopulmonary bypass with warmed oxygen are more
invasive options. Pleural and peritoneal lavage is
recommended only in patients with a normal cardiac
rhythm and a stable blood pressure. During the
rewarming process, a unique phenomenon known as
afterdrops can occur. Afterdrop occurs when the
extremities and trunk are warmed simultaneously and
cold acidotic blood from the periphery returns to core
circulation, causing acute temperature drops.
Complications of hypothermia are of particular concern.
Skin damage from both cold exposure (i.e. frostbite and
trenchfoot) or from heating pads are common. Care must
(Continued on next page)
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be taken not to rub or massage the skin and induce
further friction-related injuries. Compartment syndrome
and gangrene are frequently seen, which can lead to limb
or digit amputation. Metabolic derangements such as
rhabdomylosis, acidosis, hyperglycemia, hypoglycemia,
and adrenal suppression can also occur. In severe
progression, renal failure, DIC, pancreatitis, sepsis and
shock liver can lead to death. Initial work up should
always consist of chest x-rays, ECG and complete
laboratory studies including TSH, cortisol, electrolytes,
CBC, LFTs, pancreatic enzymes, serial arterial blood
gases, and coagulation studies. Head CT, urine drug
screen and blood alcohol level in the unresponsive patient
can help rule out other etiologies of syncope. Empiric
antibiotics, thiamine, dextrose, and naloxone for patients
with altered mental status should also be considered.
In summary, the management of the hypothermic
patients focuses on combined resuscitative and
rewarming techniques. Resuscitation efforts should be
continued until the patient is adequately rewarmed, as
arrhythmias can be refractory to standard therapies until
the core body temperature is reached. The low
temperatures do have a protective effect on neurological
function, allowing for patients to recover after a
prolonged arrest. Complications can still occur long after
rewarming, and careful monitoring of the patient in a
critical care setting is essential.
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A Man with Shortness of Breath and an Abnormal ECG: A Short Case
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An 80 year-old Chinese male with a history of tobacco
use and asthma presented to the ER complaining of
shortness of breath that was unresponsive to
bronchodilator use. The patient’s ECG on admission was
sinus rhythm at 95 beats per minute with minimal ST
elevations in V2-V4. Laboratory results were significant
for a troponin of 7.7. The patient was started on anticoagulation with heparin. A transthoracic echocardiogram
revealed an ejection fraction of 25%. The patient
underwent coronary catheterization, which revealed
luminal irregularities of his coronary arteries. Figures 1
and 2 show the end diastolic and end systolic left
ventriculograms from the catheterization, respectively.

The end systolic ventriculogram demonstrates
anterolateral and apical akinesis in a pattern similar to a
“tako-tsubo,” or octopus pot. Tako-tsubo-like left
ventricular dysfunction is a transient process that can be
brought on by “stressful” circumstances, including strong
emotions and bronchoconstriction. Typically, the
patients have elevations in troponin levels, but do not
have evidence of coronary artery disease on catheterization. The left ventricular dysfunction resolves in two
to six weeks. In this patient, a transthoracic echocardiogram demonstrated normal left ventricular function
two weeks after the initial echocardiogram.

Figure 1.

Figure 2.

Abstract

Effects Of Walnut Consumption As Part Of Heart
Healthy Diet On Atherogenic Lipoprotein Subclasses
Kimberly L. Dulaney MD, John M. Morgan MD, David M Capuzzi MD,
Department of Internal Medicine and Department of Cardiology
Thomas Jefferson University Philadelphia, Pennsylvania

Nutritional therapy is fundamental in the treatment of
cardiovascular disease. Studies that utilized a low-fat diet
supplemented with 64 grams/day of walnuts have shown
a significant reduction in serum levels of total and LDL
cholesterol, and triglycerides. This study was designed to
see if lipoprotein subclasses varied in patients eating a
low-fat walnut supplemented diet.
Methods/Design
Frozen aliquots of serum samples from a single center,
randomized, open-label, crossover study were tested to
evaluate the effects of walnut intake on lipoprotein
subclass distribution. Sixty-seven outpatients with high
total cholesterol followed a standardized low-fat, lowcholesterol diet for six weeks before random assignment
to continue the same diet or to ingest 64grams/day of
walnuts as part of the diet. A registered dietitian
instructed the patients on various ways to substitute
walnuts in their diet to maintain the same amount of
total energy, carbohydrates, protein and total fat content
as the control diet. After 6 weeks, the patients were
crossed over to the opposite treatment arm.

Results/Conclusions
Serum samples obtained pre- and post-treatment from
the walnut diet arm of the study from 42 patients were
available for analysis by Lipoprint for VLDL and LDL
particle size distribution. VLDL particles were
distributed among large (C), medium (B), and small (C)
subclasses, while LDL particles were distributed among
3 major subclasses sizes (L1-L3) ranging from the largest
(L1) to the smallest (L3). The walnut diet demonstrated
significant reduction in both the total cholesterol (5%)
and LDL-C (9%). Although the observed changes
among VLDL and LDL particle size did not significantly
change from baseline, a clear trend of -14% was observed
for the small (L3) subclass of LDL. An additional trend
in reduction of the large VLDL particle subclass (C) of
20% was also observed. Therefore, patients whose total
and LDL cholesterol levels decreased by adherence to a
low cholesterol, low fat diet enriched by 64grams/day of
walnuts also demonstrated a potentially beneficial trend
in subclass size distribution of the major atherogenic
lipoproteins classes in this study group.
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Abstract

Effect Of Intravenous Pulse Cyclophosphamtoe (CYC) Therapy
On Systemic Sclerosis (Ssc) Inflammatory Lung Disease
Nicole Weinberg, MD, Nora Sandorfi, MD, Sergio A Jimenez, MD
Department of Internal Medicineand Department of Rheumatology
Thomas Jefferson University, Philadelphia, PA

Deterioration of lung function is the most frequent cause
of death in SSc. Alveolitis is considered the initiating
event of SSc lung fibrosis. Effective therapy of SSc
alveolitis is, therefore, of paramount importance. Here
we assessed the use of intravenous CYC on pulmonary
function testing(PFT) and high resolution computerized
tomography (HRCT) abnormalities in 15 patients with
SSc and alveolitis.
Methods
Fifteen patients with SSc and alveolitis diagnosed by
clinical, bronchoalveolar lavage, or HRCT findings were
treated with intravenous pulse CYC (750 mg/m2 of body
surface area) monthly for 6 months. If there was no
improvement on PFT or HRCT findings, patients were
continued with 6 monthly pulses. If the condition was
stable or improved, patients received 3 additional
bimonthly pulses. After the first year, patients continued
with CYC pulses every 3 months for one year. PFT and
HRCT of the chest were obtained during and following
therapy to determine the efficacy of CYC treatment.
Seven patients received low-dose oral corticosteroids for
reasons other than interstitial lung disease.
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Results
A regression analysis was performed after normalizing
the DLCO (diffusion capacity of the lung for carbon
monoxide), FVC (forced vital capacity), and TLC (total
lung capacity) values to the values obtained immediately
prior to initiation of treatment. This analysis revealed a
61% improvement in the DLCO at 36 months,
following initiation of CYC therapy. The FVC and the
TLC improved by 28% and 27%, respectively, during
the same period. These results were in contrast to a 35%
decline in DLCO during the 36 months prior to therapy.
FVC and TLC were essentially unchanged in the pretreatment period. HRCT showed improvement in the
ground glass appearance in 80% of the cases, while 20%
were unchanged. Fibrosis improved in 67% and
remained unchanged in 33%. Honeycombing, if present,
disappeared in every case.
Conclusion
Intravenous pulse CYC treatment alone or accompanied
by low dose corticosteroid therapy was an effective and
well tolerated treatment of SSc inflammatory lung
disease. The greatest improvement was observed in
DLCO, although there was improvement in FVC and
TLC values, as well.

Clinical Quiz

D

A

An asymptomatic 14 y/o female with a history
of Peutz-Jeugers syndrome and prior small
bowel intussusception had the above finding
during screening with capsule endoscopy.
What is the next step?

A 21 y/o healthy male acutely decompensates
and presents with a total body punctate rash and
fulminant liver and renal failure. What is the
diagnosis, based on the histologic slide above?

B
E

A 33 y/o female with intermittent right upper
quadrant pain and an abnormal abdominal
ultrasound underwent ERCP evaluation.
What abnormality is seen and what would
you recommend to this patient?

A 68 y/o woman, status
post left upper lobe
pnemonectomy for
squamous cell cancer of
the lung, presents with a 2
week history of heaviness
in her chest and dyspnea.
Thoracentesis revealed a
milky discharge. A
therapeutic fluoroscopic
procedure is shown above.
What is your diagnosis?
What is the procedure?

C

A 54y/o male with a history of sarcoidosis, in
remission from AML after recent chemotherapy
and XRT, presents with elevated LFTs and liver
nodules on ultrasound. What is shown above?

Answers on page 12
39

To study the phenomena of disease
without books is to sail an uncharted sea,
while to study books without patients is
not to go to sea at all.
Sir William Osler
Aphorisms

